[
    {
        "chrom":"chr1",
        "start_hg38":94418422,
        "stop_hg38":94418444,
        "start_hg19":94883978,
        "stop_hg19":94884000,
        "start_t2t":94266545,
        "stop_t2t":94266567,
        "id":"OPDM_ABCD3",
        "disease_id":"OPDM",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCC"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CCG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Oculopharyngodistal myopathy",
        "gene":"ABCD3",
        "flank_motif":null,
        "locus_structure":"(GCC)*",
        "inheritance":[
            "AD"
        ],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":3.0,
        "benign_max":44.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":118.0,
        "pathogenic_max":694.0,
        "ref_copies":7.7,
        "motif_len":3,
        "age_onset":"Typical: 24-30; Range: 10-50 [@url:medrxiv.org/content/10.1101/2023.10.09.23296582v1].",
        "age_onset_min":10,
        "age_onset_max":50,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":null,
        "mechanism_detail":"Potentially over-expression of transcripts [@url:medrxiv.org/content/10.1101/2023.10.09.23296582v1].",
        "source":[
            "[@url:medrxiv.org/content/10.1101/2023.10.09.23296582v1]."
        ],
        "details":"Characterized in eight unrelated families which were used to establish benign (3-44) and pathogenic (118-694) ranges [@url:medrxiv.org/content/10.1101/2023.10.09.23296582v1].",
        "omim":[],
        "prevalence":null,
        "prevalence_details":"Found in individuals of European ancestry [@pmid:38876750].",
        "stripy":[],
        "gnomad":[],
        "genereviews":[],
        "mondo":[
            "0025193"
        ],
        "year":"2023 [@url:medrxiv.org/content/10.1101/2023.10.09.23296582v1]",
        "medgen":[
            "320250"
        ],
        "orphanet":[
            "98897"
        ],
        "gard":[
            "12592"
        ],
        "malacard":[],
        "webstr_hg38":[
            "1164141",
            "6329150"
        ],
        "webstr_hg19":[
            "STR_58687"
        ],
        "tr_gnomad":[
            "TR5671"
        ],
        "disease_description":"Oculopharyngodistal myopathy (OPDM) is a rare, adult-onset hereditary muscle disease. People with OPDM present with progressive eye and throat (pharyngeal) problems and involvement of the muscles of the lower legs and arms. Symptoms may include eyelid drooping (ptosis), swallowing difficulty, hoarse and nasal voice, leg and arm weakness, as well as muscle wasting in the face and in the legs and arms. Many people have respiratory problems due to respiratory muscle weakness. In rare cases, there is also hearing loss, as well as severe weakness in muscles of the forearms and thighs. As the disease progresses, other muscles may be affected. A blood exam may show an increased creatine kinase level and an abnormal EMG [@mondo:0025193].",
        "locus_tags":[],
        "disease_tags":["Oculopharyngodistal myopathy"]
    },
    {
        "chrom":"chrX",
        "start_hg38":148500605,
        "stop_hg38":148500753,
        "start_hg19":147582125,
        "stop_hg19":147582273,
        "start_t2t":146765191,
        "stop_t2t":146765342,
        "id":"FRAXE_AFF2",
        "disease_id":"FRAXE",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCC"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CCG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Fragile X syndrome, FRAXE type",
        "gene":"AFF2",
        "flank_motif":null,
        "locus_structure":"(GCC)*",
        "inheritance":[
            "XR"
        ],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":4.0,
        "benign_max":39.0,
        "intermediate_min":40.0,
        "intermediate_max":200,
        "pathogenic_min":201.0,
        "pathogenic_max":2000.0,
        "ref_copies":50.3,
        "motif_len":3,
        "age_onset":"Typical: 2-10 [@pmid:11246464]. Range: 1-10; developmental delays without physical features can make onset difficult to detect until schooling [@omim:309548].",
        "age_onset_min":1,
        "age_onset_max":10,
        "typ_age_onset_min":2.0,
        "typ_age_onset_max":10.0,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Loss of function via transcriptional silencing [@pmid:16205714; @pmid:36169768].",
        "source":[],
        "details":"Allele ranges (benign:4-39; pathogenic: >200) inferred from The Human Gene Mutation Database [@genereviews:NBK535148]. Intermediate alleles correspond to a premutation [@pmid:23914978]. Non-canonical motifs include: CGG/CCT/GTG/CAG/CTG3 [@pmid:35245110; @pmid:34111553].",
        "omim":[
            "309548"
        ],
        "prevalence":"2/50000",
        "prevalence_details":"1-4/100,000 males [@url:medlineplus.gov/genetics/condition/fragile-xe-syndrome]; 1/50-100,000 males, more than 50 families [@pmid:11246464]. Found in populations around the globe, including in the UK, US, Canada, Taiwan, Germany, Greece, Cyprus, Spain, and Finland [@pmid:11246464].",
        "stripy":[
            "AFF2"
        ],
        "gnomad":[
            "AFF2"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0010659"
        ],
        "year":"1993 [@pmid:8334699]",
        "medgen":[
            "155512"
        ],
        "orphanet":[
            "100973"
        ],
        "gard":[
            "2378"
        ],
        "malacard":[
            "INT399"
        ],
        "webstr_hg38":[],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR173976"
        ],
        "disease_description":"A nonsyndromic X-linked mental retardation (NS-XLMR) characterized by mild intellectual deficit. FRAXE is the most common form of NS-XLMR [@mondo:0010659].",
        "locus_tags":["somatic_instability", "anticipation", "maternal expansion", "length_affects_penetrance", "length_affects_severity"],
        "disease_tags":[]
    },
    {
        "chrom":"chr2",
        "start_hg38":100104799,
        "stop_hg38":100104824,
        "start_hg19":100721261,
        "stop_hg19":100721286,
        "start_t2t":100563686,
        "stop_t2t":100563738,
        "id":"FRA2A_AFF3",
        "disease_id":"FRA2A",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "GCC"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Intellectual disability associated with fragile site FRA2A",
        "gene":"AFF3",
        "flank_motif":null,
        "locus_structure":"(GCC)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 3",
        "benign_min":3.0,
        "benign_max":20.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":300.0,
        "pathogenic_max":300.0,
        "ref_copies":8.7,
        "motif_len":3,
        "age_onset":"Early childhood (small sample size) [@pmid:24763282].",
        "age_onset_min":1,
        "age_onset_max":7,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF/methylation",
        "mechanism_detail":"Silencing of the FMR2 gene as a consequence of a CCG expansion located upstream of this gene [@malacard:KNS007].",
        "source":[],
        "details":"Allele ranges established in study of 3 families; intermediate alleles likely premutations [@pmid:24763282]. Pathogenic threshold may be higher than 300 as this was the largest allele that could be accurately sized by the assay.",
        "omim":[
            "601464"
        ],
        "prevalence":null,
        "prevalence_details":"1/862 (1/654-1266) population prevalence of methylated AFF3 expansions (mild cognitive disability) [@url:medrxiv.org/content/10.1101/2023.05.03.23289461v1.full.pdf]. Disease cases observed in South Australia [@pmid:24763282].",
        "stripy":[],
        "gnomad":[],
        "genereviews":[],
        "mondo":[],
        "year":"2014 [@pmid:24763282]",
        "medgen":[],
        "orphanet":[],
        "gard":[],
        "malacard":[
            "KNS007"
        ],
        "webstr_hg38":[
            "288936"
        ],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR252468"
        ],
        "disease_description":"These expansions are associated with intellectual disability and clinical phenotypes such as delayed motor development or delays in speech/language [@pmid:24763282].",
        "locus_tags":[],
        "disease_tags":[]
    },
    {
        "chrom":"chrX",
        "start_hg38":67545317,
        "stop_hg38":67545419,
        "start_hg19":66765159,
        "stop_hg19":66765261,
        "start_t2t":65975148,
        "stop_t2t":65975250,
        "id":"SBMA_AR",
        "disease_id":"SBMA",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCA"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCA"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinal and bulbar muscular atrophy, Kennedy Disease",
        "gene":"AR",
        "flank_motif":null,
        "locus_structure":"(GCA)*",
        "inheritance":[
            "XR"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "benign_min":9.0,
        "benign_max":34.0,
        "intermediate_min":36.0,
        "intermediate_max":37.0,
        "pathogenic_min":38.0,
        "pathogenic_max":68.0,
        "ref_copies":34.0,
        "motif_len":3,
        "age_onset":"Typical: 20-49 [@pmid:11436124], Range: 8 [@pmid:15851746] - 78 [@pmid:19227892].",
        "age_onset_min":8,
        "age_onset_max":78,
        "typ_age_onset_min":20.0,
        "typ_age_onset_max":49.0,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Polyglutamine alters protein conformation leading to gain-of-function neurodegeneration [@pmid:29398703; @pmid:36169768]. Transcriptional dysregulation, axonal transport disruption, and mitochondrial dysfunction also play causative roles in the neurodegeneration [@pmid:22609045].",
        "source":[
            "[@pmid:2062380]."
        ],
        "details":"Intermediate alleles indicate reduced penetrance [@genereviews:NBK1333]. Expansions larger than the pathogenic threshold in the AR gene should be evaluated carefully. Interruptions have not been observed in patient cases; it has been proposed that longer alleles with interruptions may not be pathogenic [@pmid:24041967]. Non-canonical motif CAA observed [@pmid:35245110]. Expansions are also detected ten-fold more often in a general population than would be expected by disease prevalence [@pmid:36797998]. Clinical evaluation and phenotypic matching may be necessary to determine diagnosis even in the presence of a pure expanded allele. It has been proposed that contractions may play a role in disease [@pmid:10398229]. Disease may be subclinical in females [@pmid:34922802], and can be clinically heterogeneous even within the same family [@pmid:20184516].",
        "omim":[
            "313200"
        ],
        "prevalence":"1/30000",
        "prevalence_details":"1-2/100,000 (population-specific, higher in Finnish population, Canadian population) [@pmid:37628685]; 1/30,000 [@orphanet:481]; mutation frequency of 1:3182 10x more frequent than reported disease prevalence of 1 in 30,000 [@pmid:36797998]. Only documented in patients with European/Asian ancestry, including Scandinavian, English, Belgian, French, Italian, German, Polish, Spanish, Swiss, Moroccan, Turkish, Chinese, Japanese (more common because of a founder effect), Korean, and Vietnamese populations [@genereviews:NBK1333].",
        "stripy":[
            "AR"
        ],
        "gnomad":[
            "AR"
        ],
        "genereviews":[
            "NBK1333"
        ],
        "mondo":[
            "0010735"
        ],
        "year":"1991 [@pmid:2062380]; the first triplet disease to be discovered [@pmid:15313856]",
        "medgen":[
            "333282"
        ],
        "orphanet":[
            "481"
        ],
        "gard":[
            "6818"
        ],
        "malacard":[
            "SPN404"
        ],
        "webstr_hg38":[
            "859199"
        ],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR169377"
        ],
        "disease_description":"Kennedy's disease, also known as bulbospinal muscular atrophy (BSMA), is a rare X-linked recessive motor neuron disease characterized by proximal and bulbar muscle wasting [@mondo:0010735].",
        "locus_tags":["contraction", "somatic_instability", "anticipation", "paternal_expansion", "length_affects_severity", "length_affects_penetrance", "length_affects_onset"],
        "disease_tags":[]
    },
    {
        "chrom":"chrX",
        "start_hg38":25013649,
        "stop_hg38":25013697,
        "start_hg19":25031766,
        "stop_hg19":25031814,
        "start_t2t":24597886,
        "stop_t2t":24597934,
        "id":"EIEE1_ARX",
        "disease_id":"EIEE1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Early-infantile epileptic encephalopathy",
        "gene":"ARX",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "inheritance":[
            "XR"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 2, aa 110-115",
        "benign_min":10.0,
        "benign_max":16.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":17.0,
        "pathogenic_max":27.0,
        "ref_copies":14.7,
        "motif_len":3,
        "age_onset":"Typical: 0 [@pmid:21204215; @pmid:9307258]; Range: 0-4; 70% of cases involve infantile spasms, leading to seizures by 3 or 4 years [@pmid:19587282].",
        "age_onset_min":0,
        "age_onset_max":4,
        "typ_age_onset_min":0.0,
        "typ_age_onset_max":0.0,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Polyalanine expansions lead to reduction in protein product through unclear mechanism [@pmid:36169768; @pmid:38467784]. Apparent aggregation and mis-localisation of mutan protein, increased with expansion length [@genereviews:NBK51932].",
        "source":[],
        "details":"ARX expansions [@genereviews:NBK535148] result in a phenotypic spectrum of conditions including Partington syndrome [@omim:309510], Early Infantile Epileptic Encephalopathy [@omim:308350], Agenesis of Corpus Callosum with Abnormal Genitalia [@omim:300004], and X-Linked Lissencephaly with Ambiguous Genitalia [@omim:300215], described in the literature [@pmid:26029707; @pmid:20506206].",
        "omim":[
            "308350",
            "300419",
            "300215"
        ],
        "prevalence":null,
        "prevalence_details":"Found in individuals of multiple ethnicities, including European and Asian ancestry [@pmid:12874418].",
        "stripy":[
            "ARX_1"
        ],
        "gnomad":[
            "ARX_1"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0010632"
        ],
        "year":"2002 [@pmid:11889467]",
        "medgen":[
            "483052"
        ],
        "orphanet":[
            "182079"
        ],
        "gard":[
            "15298"
        ],
        "malacard":[
            "ERL057"
        ],
        "webstr_hg38":[
            "843651"
        ],
        "webstr_hg19":[
            "STR_1542607"
        ],
        "tr_gnomad":[
            "TR167317"
        ],
        "disease_description":"Developmental and epileptic encephalopathy-1 (DEE1) is a severe form of epilepsy characterized by frequent tonic seizures or spasms beginning in infancy with a specific EEG finding of suppression-burst patterns, characterized by high-voltage bursts alternating with almost flat suppression phases [@omim:308350].",
        "locus_tags":["length_affects_phenotype"],
        "disease_tags":["phenotypic spectrum"]
    },
    {
        "chrom":"chrX",
        "start_hg38":25013530,
        "stop_hg38":25013565,
        "start_hg19":25031647,
        "stop_hg19":25031682,
        "start_t2t":24597767,
        "stop_t2t":24597799,
        "id":"PRTS_ARX",
        "disease_id":"PRTS",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Partington syndrome",
        "gene":"ARX",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "inheritance":[
            "XR"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 2, aa 144-155",
        "benign_min":12.0,
        "benign_max":12.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":20.0,
        "pathogenic_max":20.0,
        "ref_copies":12.0,
        "motif_len":3,
        "age_onset":"Typical: 1-3; Range: 0-4. Mild phenotypes can make diagnosis difficult (expansions are particularly mild/absent in females) [@omim:309510].",
        "age_onset_min":0,
        "age_onset_max":4,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Polyalanine expansions lead to reduction in protein product through unclear mechanism [@pmid:36169768; @pmid:38467784]. Apparent aggregation and mis-localisation of mutan protein, increased with expansion length [@genereviews:NBK51932].",
        "source":[],
        "details":"ARX expansions [@genereviews:NBK535148] result in a phenotypic spectrum of conditions including Partington syndrome [@omim:309510], Early Infantile Epileptic Encephalopathy [@omim:308350], Agenesis of Corpus Callosum with Abnormal Genitalia [@omim:300004], and X-Linked Lissencephaly with Ambiguous Genitalia [@omim:300215], described in the literature [@pmid:26029707; @pmid:20506206].",
        "omim":[
            "309510"
        ],
        "prevalence":null,
        "prevalence_details":"Limited clinical cases of predominantly European ancestry, such as Welsh/Belgian [@omim:309510].",
        "stripy":[
            "ARX_2"
        ],
        "gnomad":[
            "ARX_2"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0010654"
        ],
        "year":"2002 [@pmid:11889467]",
        "medgen":[
            "163237"
        ],
        "orphanet":[
            "94083"
        ],
        "gard":[
            "4235"
        ],
        "malacard":[
            "PRT003"
        ],
        "webstr_hg38":[],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR167316"
        ],
        "disease_description":"A rare neurological condition that is primarily characterized by mild to moderate intellectual disability and dystonia of the hands. Other signs and symptoms may include dysarthria, behavioral abnormalities, recurrent seizures and/or an unusual gait (style of walking). Partington syndrome usually occurs in males; when it occurs in females, the signs and symptoms are often less severe. It is caused by changes (mutations) in the ARX gene and is inherited in an X-linked recessive manner. Treatment is based on the signs and symptoms present in each person [@mondo:0010654].",
        "locus_tags":["length_affects_phenotype"],
        "disease_tags":["phenotypic spectrum"]
    },
    {
        "chrom":"chr12",
        "start_hg38":6936717,
        "stop_hg38":6936775,
        "start_hg19":7045880,
        "stop_hg19":7045938,
        "start_t2t":6947904,
        "stop_t2t":6947941,
        "id":"DRPLA_ATN1",
        "disease_id":"DRPLA",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "CAG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CAG"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Dentatorubral-Pallidoluysian Atrophy",
        "gene":"ATN1",
        "flank_motif":null,
        "locus_structure":"(CAG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 5",
        "benign_min":6.0,
        "benign_max":35.0,
        "intermediate_min":36.0,
        "intermediate_max":47.0,
        "pathogenic_min":48.0,
        "pathogenic_max":93.0,
        "ref_copies":19.0,
        "motif_len":3,
        "age_onset":"Typical: 20-40 [@pmid:6808417; @genereviews:NBK1491]. Range: 0 [@pmid:11160976] - 72 [@genereviews:NBK1491].",
        "age_onset_min":0,
        "age_onset_max":72,
        "typ_age_onset_min":20.0,
        "typ_age_onset_max":40.0,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Polyglutamine expansions leading to gain of function [@genereviews:NBK1491].",
        "source":[],
        "details":"Pathogenic expansions (48-93) are fully penetrant with the exception of one documented case of 51 repeats; intermediate alleles (36-47) are associated with a milder phenotype and can expand upon transmission [@genereviews:NBK1491]. CAA interruptions have been observed without known clinical association [@pmid:35245110].",
        "omim":[
            "125370"
        ],
        "prevalence":"4.5/1000000",
        "prevalence_details":"2-7/1,000,000. More prevalent in Japanese populations; also reported in North America, South America, Europe, and Australia [@genereviews:NBK1491].",
        "stripy":[
            "ATN1"
        ],
        "gnomad":[
            "ATN1"
        ],
        "genereviews":[
            "NBK1491"
        ],
        "mondo":[
            "0007435"
        ],
        "year":"1994 [@pmid:7842016]",
        "medgen":[
            "155630"
        ],
        "orphanet":[
            "101"
        ],
        "gard":[
            "5643"
        ],
        "malacard":[
            "DNT005"
        ],
        "webstr_hg38":[
            "5050156"
        ],
        "webstr_hg19":[
            "Expansion_ATN1/DRPLA"
        ],
        "tr_gnomad":[
            "TR114246"
        ],
        "disease_description":"Dentatorubral pallidoluysian atrophy (DRPLA) is a rare subtype of type I autosomal dominant cerebellar ataxia (ADCA type I). It is characterized by involuntary movements, ataxia, epilepsy, mental disorders, cognitive decline and prominent anticipation [@mondo:0007435].",
        "locus_tags":["anticipation", "somatic_instability", "paternal_expansion", "length_affects_onset", "length_affects_severity", "length_affects_phenotype"],
        "disease_tags":[
            "ataxia",
            "epilepsy"
        ]
    },
    {
        "chrom":"chr6",
        "start_hg38":16327634,
        "stop_hg38":16327724,
        "start_hg19":16327865,
        "stop_hg19":16327955,
        "start_t2t":16200189,
        "stop_t2t":16200282,
        "id":"SCA1_ATXN1",
        "disease_id":"SCA1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "CTG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CTG"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinocerebellar Ataxia Type 1",
        "gene":"ATXN1",
        "flank_motif":null,
        "locus_structure":"(CTG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 8",
        "benign_min":6.0,
        "benign_max":35.0,
        "intermediate_min":36.0,
        "intermediate_max":38.0,
        "pathogenic_min":39.0,
        "pathogenic_max":91.0,
        "ref_copies":30.3,
        "motif_len":3,
        "age_onset":"Typical: 20-39 [@uptodate:'Autosomal dominant spinocerebellar ataxias']; Range: 6 [@pmid:3165612] - 63 [@pmid:8825276].",
        "age_onset_min":6,
        "age_onset_max":63,
        "typ_age_onset_min":20.0,
        "typ_age_onset_max":39.0,
        "novel":"ref",
        "mechanism":"GoF/LoF",
        "mechanism_detail":"Polyglutamine expansion leading to toxic gain of function with eventual misregulation-based loss of function/dominant negative [@genereviews:NBK1184; @pmid:35573049].",
        "source":["[@pmid:8358429]"],
        "details":"Penetrance is dependent on sequence purity in addition to expansion length: pure repeats are pathogenic at 39 repeats [@pmid:37906407], while CAT interruptions [@pmid:35245110] can lead to reduced penetrance at comparable lengths [@genereviews:NBK1184]. Regardless, intermediate alleles are considered premutations which may lead to disease upon transmission [@genereviews:NBK1184].",
        "omim":[
            "164400"
        ],
        "prevalence":"1.5/100000",
        "prevalence_details":"1-2/100,000. Cases have been reported worldwide, although prevalences varies by ancestry/ethnicity [@genereviews:NBK1184].",
        "stripy":[
            "ATXN1"
        ],
        "gnomad":[
            "ATXN1"
        ],
        "genereviews":[
            "NBK1184"
        ],
        "mondo":[
            "0008119"
        ],
        "year":"1993 [@pmid:8358429]",
        "medgen":[
            "155703"
        ],
        "orphanet":[
            "98755"
        ],
        "gard":[
            "4071"
        ],
        "malacard":[
            "SPN294"
        ],
        "webstr_hg38":[
            "5767842"
        ],
        "webstr_hg19":[
            "Expansion_SCA1/ATXN1"
        ],
        "tr_gnomad":[
            "TR63118"
        ],
        "disease_description":"Spinocerebellar ataxia type 1 (SCA1) is a subtype of type I autosomal dominant cerebellar ataxia (ADCA type I) characterized by dysarthria, writing difficulties, limb ataxia, and commonly nystagmus and saccadic abnormalities [@mondo:0008119].",
        "locus_tags":["somatic_instability", "anticipation", "paternal_expansion", "length_affects_onset", "length_affects_penetrance", "length_affects_severity", "motif_affects_instability", "motif_affects_onset", "motif_affects_penetrance", "motif_affects_severity"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr22",
        "start_hg38":45795355,
        "stop_hg38":45795424,
        "start_hg19":46191235,
        "stop_hg19":46191304,
        "start_t2t":46280060,
        "stop_t2t":46280129,
        "id":"SCA10_ATXN10",
        "disease_id":"SCA10",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "ATTCT"
        ],
        "pathogenic_motif_reference_orientation":[
            "ATTCT"
        ],
        "pathogenic_motif_gene_orientation":[
            "ATTCT"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinocerebellar Ataxia Type 10",
        "gene":"ATXN10",
        "flank_motif":null,
        "locus_structure":"(ATTCT)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 9",
        "benign_min":10.0,
        "benign_max":32.0,
        "intermediate_min":33.0,
        "intermediate_max":850.0,
        "pathogenic_min":800.0,
        "pathogenic_max":4500.0,
        "ref_copies":14.0,
        "motif_len":5,
        "age_onset":"Typical: 12-48; Range: 11-83 [@genereviews:NBK1175].",
        "age_onset_min":11,
        "age_onset_max":83,
        "typ_age_onset_min":12.0,
        "typ_age_onset_max":48.0,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Transdominant mechanism theorized [@pmid:38467784].",
        "source":"[@pmid:11017075]",
        "details":"Unaffected individuals are usually (82%) compound heterozygotes in the benign range [@genereviews:NBK1175]. Intermediate alleles show reduced penetrance, and exact distinction between intermediate and the lower end of the pathogenic range is unclear [@genereviews:NBK1175]. Expansions are frequently interrupted by ATCCT, ATCCC, ATTCC, ATTTCT, ATATTCT, ATTCTTCT, or ATTCTTCT; interruptions of ATTGT, TTTCT, ATTTTCT, ATTCTCT have been noted [@pmid:36199580] as has the interruption ATGCT [@pmid:19234597]. The ATCCT interruption motif is associated with a higher prevalence of epileptic seizures [@pmid:24318420].",
        "omim":[
            "603516"
        ],
        "prevalence":null,
        "prevalence_details":"Unknown prevalence, >300 individuals. Cases have been identified in Mexico, Brazil, China, and Japan [@genereviews:NBK1175].",
        "stripy":[
            "ATXN10"
        ],
        "gnomad":[
            "ATXN10"
        ],
        "genereviews":[
            "NBK1175"
        ],
        "mondo":[
            "0011330"
        ],
        "year":"2000 [@pmid:8358429]",
        "medgen":[
            "369786"
        ],
        "orphanet":[
            "98761"
        ],
        "gard":[
            "10474"
        ],
        "malacard":[
            "SPN314"
        ],
        "webstr_hg38":[
            "1027359",
            "4921433"
        ],
        "webstr_hg19":[
            "STR_909210"
        ],
        "tr_gnomad":[
            "TR165509"
        ],
        "disease_description":"Spinocerebellar ataxia type 10 (SCA10) is a subtype of type I autosomal dominant cerebellar ataxia (ADCA type I). It is characterized by slowly progressive cerebellar syndrome and epilepsy, sometimes mild pyramidal signs, peripheral neuropathy and neuropsychological disturbances [@mondo:0011330].",
        "locus_tags":["somatic_instability", "anticipation", "paternal_expansion", "length_affects_onset", "length_affects_penetrance", "length_affects_phenotype", "motif_affects_instability", "motif_affects_penetrance", "motif_affects_phenotype"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr12",
        "start_hg38":111598950,
        "stop_hg38":111599019,
        "start_hg19":112036754,
        "stop_hg19":112036823,
        "start_t2t":111575873,
        "stop_t2t":111575940,
        "id":"SCA2_ATXN2",
        "disease_id":"SCA2",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "CTG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CTG"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinocerebellar Ataxia Type 2",
        "gene":"ATXN2",
        "flank_motif":null,
        "locus_structure":"(CTG)*",
        "inheritance":[
            "AD",
            "AR"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "benign_min":14.0,
        "benign_max":30.0,
        "intermediate_min":31.0,
        "intermediate_max":34.0,
        "pathogenic_min":35.0,
        "pathogenic_max":500.0,
        "ref_copies":23.3,
        "motif_len":3,
        "age_onset":"Typical: 30-39 [@genereviews:NBK1275]; Range: 2-86 [@omim:183090].",
        "age_onset_min":2,
        "age_onset_max":86,
        "typ_age_onset_min":30.0,
        "typ_age_onset_max":39.0,
        "novel":"ref",
        "mechanism":"GoF/LoF",
        "mechanism_detail":"Polyglutamine cytoplasmic aggregates leading to cellular apoptosis; RAN translation implicated [@genereviews:NBK1275].",
        "source":[],
        "details":"Full penetrance of single alleles occurs at ~35 repeats [@genereviews:NBK1275; @pmid:37906407] and pathogenic expansions have been documented as large as 500 repeats [@pmid:12116207]. 33-34 length repeats are associated with reduced penetrance [@genereviews:NBK1275]. Homozygous 31 repeat alleles may lead to disease, while a single 30-32 repeat is associated with increased ALS risk and 33 [@genereviews:NBK1275]. Interruptions observed include CAA, CGG, CGC, which appear to stabilize the allele in transmission [@genereviews:NBK1275]. May confer risk for amyotrophic lateral sclerosis [@pmid:32954321].",
        "omim":[
            "183090"
        ],
        "prevalence":"1.5/100000",
        "prevalence_details":"1-2/100,000 (population-dependent) [@pmid:29100084]. Cases have been found across ethnicities/ancestries, with population-dependent prevalence [@genereviews:NBK1275].",
        "stripy":[
            "ATXN2"
        ],
        "gnomad":[
            "ATXN2"
        ],
        "genereviews":[
            "NBK1275"
        ],
        "mondo":[
            "0008458"
        ],
        "year":"1996 [@pmid:8896556]",
        "medgen":[
            "155704"
        ],
        "orphanet":[
            "98756"
        ],
        "gard":[
            "4072"
        ],
        "malacard":[
            "SPN301"
        ],
        "webstr_hg38":[
            "598560",
            "5117050"
        ],
        "webstr_hg19":[
            "Expansion_SCA2/ATXN2"
        ],
        "tr_gnomad":[
            "TR120465"
        ],
        "disease_description":"A subtype of type I autosomal dominant cerebellar ataxia (ADCA type I) characterized by truncal ataxia, dysarthria, slowed saccades and less commonly ophthalmoparesis and chorea [@mondo:0008458].",
        "locus_tags":["somatic_instability", "anticipation", "paternal_expansion", "maternal expansion", "length_affects_onset", "length_affects_penetrance", "length_affects_phenotype", "length_affects_severity", "motif_affects_instability", "motif_affects_phenotype", "proposed_modifier"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr14",
        "start_hg38":92071012,
        "stop_hg38":92071053,
        "start_hg19":92537356,
        "stop_hg19":92537397,
        "start_t2t":86300520,
        "stop_t2t":86300603,
        "id":"SCA3_ATXN3",
        "disease_id":"SCA3, MJD",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "CTG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CTG"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinocerebellar Ataxia Type 3/Machado-Joseph Disease",
        "gene":"ATXN3",
        "flank_motif":null,
        "locus_structure":"(CTG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 10",
        "benign_min":11.0,
        "benign_max":44.0,
        "intermediate_min":45.0,
        "intermediate_max":59.0,
        "pathogenic_min":60.0,
        "pathogenic_max":87.0,
        "ref_copies":14.0,
        "motif_len":3,
        "age_onset":"Typical: 10-49 [@genereviews:NBK1196]; 5-73 [@genereviews:NBK1196; @pmid:30414314].",
        "age_onset_min":5,
        "age_onset_max":73,
        "typ_age_onset_min":10.0,
        "typ_age_onset_max":49.0,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Polyglutamine expansion leading to gain of function; aggregated and mislocalized proteins in neurons [@pmid:36169768; @genereviews:NBK1196].",
        "source":[],
        "details":"Benign alleles range from 11-44 repeats [@pmid:37906407], with intermediate alleles (45-59) associated with incomplete penetrance and non-classic phenotypes [@genereviews:NBK1196]. The threshold between incomplete and full penetrance is unclear, but presumed to occur at ~60 repeats [@genereviews:NBK1196; @pmid:37906407]. The interruption CAA has been observed [@pmid:35245110]; AAG is present in hg38 reference sequence.",
        "omim":[
            "109150"
        ],
        "prevalence":"2.1/100000",
        "prevalence_details":"1-5/100,000 [@pmid:29100084]. Most prevalent SCA subtype [@genereviews:NBK557816]. Found worldwide across ancestries/ethnicities [@genereviews:NBK1196].",
        "stripy":[
            "ATXN3"
        ],
        "gnomad":[
            "ATXN3"
        ],
        "genereviews":[
            "NBK1196"
        ],
        "mondo":[
            "0007182"
        ],
        "year":"1994 [@pmid:7874163]",
        "medgen":[
            "9841"
        ],
        "orphanet":[
            "98757"
        ],
        "gard":[
            "6801"
        ],
        "malacard":[
            "MCH002"
        ],
        "webstr_hg38":[
            "5316666",
            "1481402"
        ],
        "webstr_hg19":[
            "Expansion_SCA3_MJD/ATXN3"
        ],
        "tr_gnomad":[
            "TR132758"
        ],
        "disease_description":"Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease, is the most common subtype of type 1 autosomal dominant cerebellar ataxia (ADCA type 1), a neurodegenerative disorder, and is characterized by ataxia, external progressive ophthalmoplegia, and other neurological manifestations [@mondo:0007182].",
        "locus_tags":["somatic_instability", "anticipation", "paternal_expansion", "maternal expansion", "length_affects_onset", "length_affects_phenotype", "length_affects_severity"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr3",
        "start_hg38":63912685,
        "stop_hg38":63912716,
        "start_hg19":63898361,
        "stop_hg19":63898392,
        "start_t2t":63956303,
        "stop_t2t":63956334,
        "id":"SCA7_ATXN7",
        "disease_id":"SCA7",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "CAG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CAG"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinocerebellar Ataxia Type 7",
        "gene":"ATXN7",
        "flank_motif":"(CAG)n(CCG)4",
        "locus_structure":"(CAG)*(CCG)+",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1, 2, or 3 (depending on isoform)",
        "benign_min":4.0,
        "benign_max":27.0,
        "intermediate_min":28.0,
        "intermediate_max":35.0,
        "pathogenic_min":37.0,
        "pathogenic_max":460.0,
        "ref_copies":10.7,
        "motif_len":3,
        "age_onset":"Typical: 4-48 [@pmid:20739808]; Range: 0-90 [@genereviews:NBK1256; @pmid:14571264].",
        "age_onset_min":0,
        "age_onset_max":65,
        "typ_age_onset_min":4.0,
        "typ_age_onset_max":48.0,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Polyglutamine expansion leading to gain of function; toxic misfolded intermediated suspected [@genereviews:NBK1256; @pmid:18418675].",
        "source":[
        ],
        "details":"Benign alleles range from 4-27 [@pmid:37906407], with intermediate alleles ranging from premutations (28-33) to reduced penetrance (34-36) [@genereviews:NBK1256]. Interruptions observed include CAA [@pmid:35245110].",
        "omim":[
            "164500"
        ],
        "prevalence":"0.999/300000",
        "prevalence_details":"<1/300,000: predominantly found in those with North European and African ancestry [@genereviews:NBK1256].",
        "stripy":[
            "ATXN7"
        ],
        "gnomad":[
            "ATXN7"
        ],
        "genereviews":[
            "NBK1256"
        ],
        "mondo":[
            "0016163"
        ],
        "year":"1996 [@pmid:8908515]",
        "medgen":[
            "156006"
        ],
        "orphanet":[
            "94147"
        ],
        "gard":[
            "20405"
        ],
        "malacard":[
            "SPN291"
        ],
        "webstr_hg38":[
            "4965588"
        ],
        "webstr_hg19":[
            "Expansion_SCA7/ATXN7"
        ],
        "tr_gnomad":[
            "TR31879",
            "TR31880"
        ],
        "disease_description":"Spinocerebellar ataxia-7 (SCA7) is an autosomal dominant neurodegenerative disorder characterized by adult onset of progressive cerebellar ataxia associated with pigmental macular dystrophy [@omim:164500].",
        "locus_tags":["somatic_instability", "anticipation", "paternal_expansion", "length_affects_onset", "length_affects_penetrance", "length_affects_phenotype", "length_affects_severity"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr13",
        "start_hg38":70139383,
        "stop_hg38":70139429,
        "start_hg19":70713515,
        "stop_hg19":70713561,
        "start_t2t":69361244,
        "stop_t2t":69361271,
        "id":"SCA8_ATXN8OS",
        "disease_id":"SCA8",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "CTG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CTG"
        ],
        "pathogenic_motif_gene_orientation":[
            "CTG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinocerebellar Ataxia Type 8",
        "gene":"ATXN8OS",
        "flank_motif":"(CTA)10(CTG)n",
        "locus_structure":"(CTA)*(CTG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding/3' UTR",
        "location_in_gene":"Exon 1 or 3' UTR depending on transcript",
        "benign_min":15.0,
        "benign_max":50.0,
        "intermediate_min":50.0,
        "intermediate_max":70.0,
        "pathogenic_min":71.0,
        "pathogenic_max":1300.0,
        "ref_copies":15.3,
        "motif_len":3,
        "age_onset":"Typical: 20-40; Range: 0-73 [@genereviews:NBK1268].",
        "age_onset_min":1,
        "age_onset_max":73,
        "typ_age_onset_min":20.0,
        "typ_age_onset_max":49.0,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Polyglutamine/toxic gain-of-function [@omim:608768; @genereviews:NBK1268].",
        "source":[],
        "details":"Two genes span the CTG/CAG repeat and are expressed in opposite directions: ATXN8, a nearly pure polyglutamine repeat protein in the CAG direction, and ATXN8OS, which is transcribed to a noncoding CUG repeat RNA [@pmid:16804541]. Reduced penetrance is found in alleles of all sizes, although penetrance appears higher at 71+ repeats and repeats at 50-70 appear less likely to result in disease [@genereviews:NBK1268; @pmid:20373340]. Roda et al. suggested that the ATXN8 or ATXN8OS gene should not be evaluated in isolation as a candidate gene for spinocerebellar degenerative disease [@pmid:28451643]. CCG/CGG interruptions in high-penetrance SCA8 families increase RAN translation and protein toxicity [@pmid:34632710]; Interruptions in CTG/CAG expansion by 1 or more CCG/CGG, CTA/TAG, CTC/GAG, CCA/TGG, or CTT/AAG trinucleotides have been observed in full-penetrance repeats [@pmid:16804541; @genereviews:NBK1268].",
        "omim":[
            "608768"
        ],
        "prevalence":"0.5/100000",
        "prevalence_details":"<1/100,000 [@pmid:29100084]; expansion in 1:100-1200 chromosomes [@genereviews:NBK1268]. Found across ethnicities/ancestries, with population-dependent prevalence [@genereviews:NBK1268].",
        "stripy":[
            "ATXN8OS"
        ],
        "gnomad":[
            "ATXN8OS"
        ],
        "genereviews":[
            "NBK1268"
        ],
        "mondo":[
            "0012116"
        ],
        "year":"1999 [@pmid:10192387]",
        "medgen":[
            "332457"
        ],
        "orphanet":[
            "98760"
        ],
        "gard":[
            "4956"
        ],
        "malacard":[
            "SPN304"
        ],
        "webstr_hg38":[
            "5356762"
        ],
        "webstr_hg19":[
            "Expansion_SCA8/ATXN8"
        ],
        "tr_gnomad":[
            "TR125263",
            "TR125264"
        ],
        "disease_description":"Spinocerebellar ataxia type 8 (SCA8) is a subtype of type I autosomal dominant cerebellar ataxia (ADCA type I) characterized by cerebellar ataxia and cognitive dysfunction in almost three quarters of patients and pyramidal and sensory signs in approximately a third of patients [@mondo:0012116].",
        "locus_tags":["somatic_instability", "anticipation", "maternal expansion", "motif_affects_onset", "motif_affects_penetrance"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr16",
        "start_hg38":66490397,
        "stop_hg38":66490466,
        "start_hg19":66524300,
        "stop_hg19":66524369,
        "start_t2t":72284667,
        "stop_t2t":72284761,
        "id":"SCA31_BEAN1",
        "disease_id":"SCA31",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "AATAA"
        ],
        "pathogenic_motif_reference_orientation":[
            "TGGAA",
            "TAGAA"
        ],
        "pathogenic_motif_gene_orientation":[
            "AATGG",
            "AATAG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[
            "AAAAA",
            "AAAAC",
            "AAATG",
            "AGAAA",
            "ATAAG",
            "TAAAC",
            "TAACA",
            "TACAA",
            "TCAAA",
            "TGCAA"
        ],
        "unknown_motif_gene_orientation":[
            "AAAAA",
            "AAAAC",
            "AAATG",
            "AAAAG",
            "AAGAT",
            "AAACT",
            "AACAT",
            "AATAC",
            "AAATC",
            "AATGC"
        ],
        "disease":"Spinocerebellar Ataxia Type 31",
        "gene":"BEAN1",
        "flank_motif":null,
        "locus_structure":"(TGGAA)*(TAGAA)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 4/4",
        "benign_min":null,
        "benign_max":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":110.0,
        "pathogenic_max":760.0,
        "ref_copies":14.4,
        "motif_len":5,
        "age_onset":"Typical: 56-62 [@pmid:36563608]; Range: 8-83 [@pmid:23331413].",
        "age_onset_min":8,
        "age_onset_max":83,
        "typ_age_onset_min":56.0,
        "typ_age_onset_max":62.0,
        "novel":"novel",
        "mechanism":"GoF",
        "mechanism_detail":"RNA toxicity and gain of function leading to neurodegeneration [@pmid:36371266]. Role in heterochromatin or chromosomal structure theorized [@omim:117210].",
        "source":[],
        "details":"This locus is a novel STR-containing insertion, not present in reference genome; the pathogenic threshold (110-760) is based on the pure repeat of the pathogenic motif within the insertion [@pmid:19878914].",
        "omim":[
            "117210"
        ],
        "prevalence":null,
        "prevalence_details":"Has been found in Japanese populations [@omim:117210] and then once respectively in a Korean and a Chinese family [@pmid:36563608].",
        "stripy":[
            "BEAN1"
        ],
        "gnomad":[
            "BEAN1"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0007296"
        ],
        "year":"2009 [@pmid:19878914]",
        "medgen":[
            "348439"
        ],
        "orphanet":[
            "217012"
        ],
        "gard":[
            "9975"
        ],
        "malacard":[
            "SPN103"
        ],
        "webstr_hg38":[
            "812447",
            "5971756"
        ],
        "webstr_hg19":[
            "STR_539736"
        ],
        "tr_gnomad":[
            "TR141992"
        ],
        "disease_description":"Spinocerebellar ataxia type 31 (SCA31) is a very rare subtype of autosomal dominant cerebellar ataxia type III (ADCA type III) characterized by the late-onset of cerebral ataxia, dysarthria and horizontal gaze nystagmus, and that is occasionally accompanied by pyramidal signs, tremor, decreased vibration sense and hearing difficulties [@mondo:0007296].",
        "locus_tags":["anticipation", "motif_affects_onset", "motif_affects_penetrance"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr9",
        "start_hg38":27573484,
        "stop_hg38":27573546,
        "start_hg19":27573482,
        "stop_hg19":27573544,
        "start_t2t":27584063,
        "stop_t2t":27584155,
        "id":"FTDALS1_C9orf72",
        "disease_id":"FTDALS1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "GGCCCC"
        ],
        "pathogenic_motif_reference_orientation":[
            "GGCCCC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CCGGGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Frontotemporal dementia (FTD) and/or amyotrophic lateral sclerosis (ALS)",
        "gene":"C9orf72",
        "flank_motif":null,
        "locus_structure":"(GGCCCC)*",
        "inheritance":[
            "AD"
        ],
        "type":"5' UTR/Intronic",
        "location_in_gene":"Intron 1 or 5' UTR depending on transcript",
        "benign_min":2.0,
        "benign_max":23.0,
        "intermediate_min":24.0,
        "intermediate_max":60.0,
        "pathogenic_min":251.0,
        "pathogenic_max":4000.0,
        "ref_copies":10.8,
        "motif_len":6,
        "age_onset":"Typical: 50-64; Range: 20-91 [@genereviews:NBK268647].",
        "age_onset_min":20,
        "age_onset_max":91,
        "typ_age_onset_min":50.0,
        "typ_age_onset_max":64.0,
        "novel":"ref",
        "mechanism":"Ambiguous",
        "mechanism_detail":"The HRE forms DNA and RNA G-quadruplexes with distinct structures and promotes RNA/DNA hybrids (R-loops). The structural polymorphism causes a repeat length-dependent accumulation of transcripts aborted in the HRE region [@omim:105500]. Addiitonal mechanisms theorized include protein loss of function and RNA gain of function [@pmid:37847372].",
        "source":[
        ],
        "details":"FTD and ALS form a clinical spectrum [@pmid:37388914; @pmid:22406228]. The clinical ranges of the C9orf72 locus remain ambiguous [@stripy:C9ORF72]: most healthy controls have alleles up to 24 repeats [@pmid:28319737] yet 24-30 repeats are associated with ALS [@pmid:31315673] and while 60 repeats is frequently used as a threshold for uncertain alleles, the exact threshold of pathogenicity remains unclear [@genereviews:NBK268647; @pmid:38099605]. Repeat of 80 motifs and lower appear to have delayed onset for any phenotype [@pmid:28319737]. >250 repeats are associated with a full FTD/ALS disease state [@pmid:31048495], but pathogenic alleles can range from 30 to more than 4000 repeats [@pmid:38099605]. Penetrance appears to also be age-dependent, with environmental factors and specific phenotypes associated with sex and age at onset [@pmid:28522837].",
        "omim":[
            "105500"
        ],
        "prevalence":null,
        "prevalence_details":"The expansion of a hexanucleotide repeat GGGGCC in C9orf72 is the most common known cause of ALS accounting for ~ 40% familial cases and ~ 7% sporadic cases in the European population; overall ALS incidence is 1-2/100,000 person-years, point prevalence is 3-5/100,000 (Europe/US); lifetime risk is 1 in 300 [@pmid:31315673]. Related individuals to patients with C9orf72-ALS appear at an increased risk of disease regardless of carrier status [@pmid:38149039; @pmid:39315390]. C9orf72-FTD is estimated to be 0.04-134:100,000 [@genereviews:NBK268647], and by our estimates 0.65-1.56/100,000 for C9orf72-ALS. The expansion has been found across ethnicities/ancestries, with population-dependent prevalence, highest in those with northern European ancestry [@genereviews:NBK268647].",
        "stripy":[
            "C9ORF72"
        ],
        "gnomad":[
            "C9ORF72"
        ],
        "genereviews":[
            "NBK268647"
        ],
        "mondo":[
            "0007105"
        ],
        "year":"2011 [@pmid:21944778]",
        "medgen":[
            "1830423"
        ],
        "orphanet":[
            "275872"
        ],
        "gard":[
            "18396"
        ],
        "malacard":[
            "FRN044"
        ],
        "webstr_hg38":[
            "5877863",
            "1502453"
        ],
        "webstr_hg19":[
            "STR_1475506"
        ],
        "tr_gnomad":[
            "TR92417"
        ],
        "disease_description":"Pure frontotemporal dementia, pure amyotrophic lateral sclerosis or combination of the two [@pmid:39349043].",
        "locus_tags":["length_affects_phenotype", "length_affects_onset"],
        "disease_tags":["phenotypic spectrum"]
    },
    {
        "chrom":"chr19",
        "start_hg38":13207859,
        "stop_hg38":13207898,
        "start_hg19":13318673,
        "stop_hg19":13318712,
        "start_t2t":13333137,
        "stop_t2t":13333176,
        "id":"SCA6_CACNA1A",
        "disease_id":"SCA6",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "CTG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CTG"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinocerebellar Ataxia Type 6",
        "gene":"CACNA1A",
        "flank_motif":null,
        "locus_structure":"(CTG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Last Exon: 47 or 48",
        "benign_min":4.0,
        "benign_max":18.0,
        "intermediate_min":19.0,
        "intermediate_max":19.0,
        "pathogenic_min":20.0,
        "pathogenic_max":33.0,
        "ref_copies":13.3,
        "motif_len":3,
        "age_onset":"Typical: 43-52 [@genereviews:NBK1140]; Range: 16 [@pmid:23331413] - 73 [@genereviews:NBK1140].",
        "age_onset_min":16,
        "age_onset_max":73,
        "typ_age_onset_min":43.0,
        "typ_age_onset_max":52.0,
        "novel":"ref",
        "mechanism":"GoF/LoF",
        "mechanism_detail":"Polyglutamine expansions associated increased expression of altered product leading to impaired gene binding and transcription factor function as well as cellular toxicity [@genereviews: NBK1140].",
        "source":[
        ],
        "details":"The intermediate range (19 motifs) [@pmid:37906407; @genereviews:NBK1140] can be associated with a premutation, reduced penetrance, atypical phenotype, or a disease state when homozygous [@genereviews:NBK1140].",
        "omim":[
            "183086"
        ],
        "prevalence":"2.65/100000",
        "prevalence_details":"13-15% of global SCA prevalence, estimated to be 0.02-31/100,000 [@genereviews:NBK1140; @pmid:29100084]: resultant estimate is 0.3-5/100,000. Found across ethnicities/ancestries, with population-dependent prevalence [@genereviews:NBK1140].",
        "stripy":[
            "CACNA1A"
        ],
        "gnomad":[
            "CACNA1A"
        ],
        "genereviews":[
            "NBK1140"
        ],
        "mondo":[
            "0008457"
        ],
        "year":"1997 [@pmid:8988170]",
        "medgen":[
            "148458"
        ],
        "orphanet":[
            "98758"
        ],
        "gard":[
            "10351"
        ],
        "malacard":[
            "SPN309"
        ],
        "webstr_hg38":[
            "5624835"
        ],
        "webstr_hg19":[
            "Expansion_SCA6/CACNA1A"
        ],
        "tr_gnomad":[
            "TR154515"
        ],
        "disease_description":"Spinocerebellar ataxia type 6 (SCA6) is the most common subtype of autosomal dominant cerebellar ataxia type III (ADCA type III) characterized by late-onset and slowly progressive gait ataxia and other cerebellar signs such as impaired muscle coordination and nystagmus [@mondo:0008457].",
        "locus_tags":["length_affects_phenotype", "length_affects_penetrance", "length_affects_onset"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr11",
        "start_hg38":119206289,
        "stop_hg38":119206322,
        "start_hg19":119076999,
        "stop_hg19":119077032,
        "start_t2t":119226663,
        "stop_t2t":119226696,
        "id":"JBS_CBL",
        "disease_id":"JBS",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "CGG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CGG"
        ],
        "pathogenic_motif_gene_orientation":[
            "CGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Jacobsen syndrome (FRAX11B fragile site)",
        "gene":"CBL",
        "flank_motif":null,
        "locus_structure":"(CGG)*",
        "inheritance":[
            "AD"
        ],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":5.0,
        "benign_max":79.0,
        "intermediate_min":80.0,
        "intermediate_max":100.0,
        "pathogenic_min":101.0,
        "pathogenic_max":300.0,
        "ref_copies":11.3,
        "motif_len":3,
        "age_onset":"Condition at birth.",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"Hypermethylation",
        "mechanism_detail":"DNA hypermethylation/11q deletion in sporadic cases [@pmid:38467784].",
        "source":[],
        "details":"70% of individuals have 11 repeats [@pmid:7603564], but pathogenic expansion can span hundreds of motifs [@pmid:10767345]. The CGG repeat expansion can lead to a fragile site and subsequent deletion of 11q (shown in 2 cases) but total causality is unclear; intermediate alleles are associated with a premutation [@pmid:19267933].",
        "omim":[
            "147791"
        ],
        "prevalence":null,
        "prevalence_details":"1/100,000 births; female/male ratio 2:1 [@pmid:19267933]. Found across ancestries/ethnicities [@omim:147791].",
        "stripy":[
            "CBL"
        ],
        "gnomad":[],
        "genereviews":[],
        "mondo":[
            "0007838"
        ],
        "year":"1995 [@pmid:7603564]",
        "medgen":[
            "162878"
        ],
        "orphanet":[
            "2308"
        ],
        "gard":[
            "307"
        ],
        "malacard":[
            "JCB001"
        ],
        "webstr_hg38":[
            "6166081",
            "430025"
        ],
        "webstr_hg19":[
            "STR_266122"
        ],
        "tr_gnomad":[
            "TR112816"
        ],
        "disease_description":"A multiple congenital anomaly/intellectual disability contiguous gene syndrome caused by partial deletion of the long arm of chromosome 11 [@mondo:0007838].",
        "locus_tags":[],
        "disease_tags":[]
    },
    {
        "chrom":"chr3",
        "start_hg38":129172577,
        "stop_hg38":129172659,
        "start_hg19":128891420,
        "stop_hg19":128891502,
        "start_t2t":131917483,
        "stop_t2t":131917557,
        "id":"DM2_CNBP",
        "disease_id":"DM2",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "CAGG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CAGG"
        ],
        "pathogenic_motif_gene_orientation":[
            "CCTG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Myotonic Dystrophy Type 2",
        "gene":"CNBP",
        "flank_motif":"(CAGG)n(CAGA)10(CA)19",
        "locus_structure":"(CAGG)*(CAGA)*(CA)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "benign_min":11.0,
        "benign_max":26.0,
        "intermediate_min":27.0,
        "intermediate_max":74.0,
        "pathogenic_min":75.0,
        "pathogenic_max":11000.0,
        "ref_copies":20.8,
        "motif_len":4,
        "age_onset":"Typical: 28-56 [@pmid:29086017]; Range: 0-73 [@pmid:31159885].",
        "age_onset_min":0,
        "age_onset_max":73,
        "typ_age_onset_min":28.0,
        "typ_age_onset_max":56.0,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Aberrant splicing, RAN translation [@pmid:22140091; @pmid:38467784].",
        "source":[],
        "details":"≤30 uninterrupted CCTG repeats or 11-26 CCTG repeats with GCTC/TCTG interruptions are considered benign; 27-29 repeats with interruptions have currently unknown significance, ~30-~54 repeats are considered premutations, ~55-74 repeats are premutations with possible reduced penetrance, and >74 repeat alleles are considered pathogenic [@genereviews:NBK1466]. Penetrance is age-dependent and approaches 100%. Locus structure is (TG)n(TCTG)n(CCTG)n. CCTG expansion causes DM2 but the other repeat units are also variable. Interruptions include GCTG/TCTG/GGCT [@pmid:35245110].",
        "omim":[
            "602668"
        ],
        "prevalence":"2.29/100000",
        "prevalence_details":"2.29/100,000 [@pmid:35483324]; population specific prevalence [@genereviews:NBK1466]. Most cases have European ancestry, but disease has been reported worldwide [@genereviews:NBK1466].",
        "stripy":[
            "CNBP"
        ],
        "gnomad":[
            "CNBP"
        ],
        "genereviews":[
            "NBK1466"
        ],
        "mondo":[
            "0011266"
        ],
        "year":"2001 [@pmid:11486088]",
        "medgen":[
            "419137"
        ],
        "orphanet":[
            "606"
        ],
        "gard":[
            "9728"
        ],
        "malacard":[
            "MYT020"
        ],
        "webstr_hg38":[
            "741073"
        ],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR35563",
            "TR35564",
            "TR35565"
        ],
        "disease_description":"Myotonic dystrophy type 2 (MD2), also known as proximal myotonic myopathy, is a very rare genetic multi-system disorder of late childhood or adult-onset characterized by mild myotonia, muscle weakness, and rarely cardiac conduction disorders [@mondo:0011266].",
        "locus_tags":["somatic_instability", "motif_affects_instability"],
        "disease_tags":["myotonic dystrophy"]
    },
    {
        "chrom":"chr19",
        "start_hg38":18786034,
        "stop_hg38":18786049,
        "start_hg19":18896844,
        "stop_hg19":18896859,
        "start_t2t":18921630,
        "stop_t2t":18921645,
        "id":"EDM1-PSACH_COMP",
        "disease_id":"EDM1, PSACH",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "GTC"
        ],
        "pathogenic_motif_reference_orientation":[
            "GTC"
        ],
        "pathogenic_motif_gene_orientation":[
            "ACG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Multiple epiphyseal dysplasia, Pseudoachondroplasia",
        "gene":"COMP",
        "flank_motif":null,
        "locus_structure":"(GTC)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 13",
        "benign_min":5.0,
        "benign_max":5.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":6.0,
        "pathogenic_max":7.0,
        "ref_copies":5.0,
        "motif_len":3,
        "age_onset":"Typical: 0-2 (COMP-PSACH)/ 1-12 (EDM1); Range: 0 (PSACH) - 13 (EDM1). 3-13 specific to trinucleotide expansions (duplications) [@pmid:29530484], several contractions but unknown exact AoO [@genereviews:NBK1123; @genereviews:NBK1487].",
        "age_onset_min":3,
        "age_onset_max":13,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF/GoF?",
        "mechanism_detail":"Poly-aspartic acid expansions, domain dependent [@pmid:29530484]; may involve misfolding but still unestablished [@genereviews:NBK1123].",
        "source":[],
        "details":"Both expansions to (GTC)6-7 and contractions to (GTC)4 are associated with disease [@genereviews:NBK1487].",
        "omim":[
            "132400",
            "177170"
        ],
        "prevalence":null,
        "prevalence_details":"Specific contribution of COMP repeats to EDM1 is unknown (~300 COMP mutation variants for both phenotypes); likely 1:90,000 prevalence for COMP-PSACH that is repeat-specific. Found across ancestries/ethnicities [@genereviews:NBK1123; @genereviews:NBK1487].",
        "stripy":[
            "COMP"
        ],
        "gnomad":[
            "COMP"
        ],
        "genereviews":[
            "NBK1123",
            "NBK1487"
        ],
        "mondo":[
            "0008322",
            "0007561"
        ],
        "year":"1999 [@pmid:9887340]",
        "medgen":[
            "98378",
            "325376"
        ],
        "orphanet":[
            "750",
            "93308"
        ],
        "gard":[
            "4540",
            "2180"
        ],
        "malacard":[
            "EPP017",
            "PSD012"
        ],
        "webstr_hg38":[
            "1317658"
        ],
        "webstr_hg19":[
            "STR_673389"
        ],
        "tr_gnomad":[
            "TR155017"
        ],
        "disease_description":"Pseudoachondroplasia is characterized by severe growth deficiency and deformations such as bow legs and hyperlordosis.; Multiple epiphyseal dysplasia type 1 (MED 1) is a form of multiple epiphyseal dysplasia that is characterized by normal or mild short stature, pain in the hips and/or knees, progressive deformity of extremities and early-onset osteoarthrosis. Specific features to MED 1 include a more pronounced involvement of hip joints and gait abnormality and a shorter adult height. MED1 is allelic to pseudoachondroplasia with which it shares clinical and radiological features. The disease follows an autosomal dominant mode of transmission [@mondo:0008322; @mondo:0007561].",
        "locus_tags":["contraction"],
        "disease_tags":["phenotypic spectrum"]
    },
    {
        "chrom":"chr21",
        "start_hg38":43776443,
        "stop_hg38":43776479,
        "start_hg19":45196324,
        "stop_hg19":45196360,
        "start_t2t":42132055,
        "stop_t2t":42132091,
        "id":"EPM1_CSTB",
        "disease_id":"EPM1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "CGCGGGGCGGGG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CGCGGGGCGGGG"
        ],
        "pathogenic_motif_gene_orientation":[
            "CCCCGCCCCGCG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Progressive Myoclonic Epilepsy Type 1 (EPM1) Unverricht-Lundborg Disease (ULD)",
        "gene":"CSTB",
        "flank_motif":null,
        "locus_structure":"(CGCGGGGCGGGG)*",
        "inheritance":[
            "AR"
        ],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":2.0,
        "benign_max":3.0,
        "intermediate_min":12.0,
        "intermediate_max":17.0,
        "pathogenic_min":30.0,
        "pathogenic_max":81.0,
        "ref_copies":null,
        "motif_len":12,
        "age_onset":"Typical: 6-15 [@genereviews:NBK1142]; Range: 6-18 [@pmid:18325013].",
        "age_onset_min":6,
        "age_onset_max":18,
        "typ_age_onset_min":6.0,
        "typ_age_onset_max":15.0,
        "novel":null,
        "mechanism":"LoF",
        "mechanism_detail":"LoF [@pmid:38467784].",
        "source":[],
        "details":null,
        "omim":[
            "254800"
        ],
        "prevalence":null,
        "prevalence_details":"Worldwide prevalence unknown; Finland prevalence 2-4/100,000. Found across ethnicities/ancestries, with population-dependent prevalence; highest in Tunisia, Algeria, Morocco, and Finland [@genereviews:NBK1142].",
        "stripy":[],
        "gnomad":[
            "CSTB"
        ],
        "genereviews":[
            "NBK1142"
        ],
        "mondo":[
            "0009698"
        ],
        "year":"1997 [@pmid:9126745]",
        "medgen":[
            "155923"
        ],
        "orphanet":[
            "308"
        ],
        "gard":[
            "3876"
        ],
        "malacard":[
            "MYC080"
        ],
        "webstr_hg38":[
            "5547429"
        ],
        "webstr_hg19":[
            "STR_886261"
        ],
        "tr_gnomad":[
            "TR163552"
        ],
        "disease_description":"Unverricht-Lundborg disease (ULD) is a rare progressive myoclonic epilepsy disorder characterized by action- and stimulus-sensitive myoclonus, and tonic-clonic seizures with ataxia, but with only a mild cognitive decline over time [@mondo:0009698].",
        "locus_tags":["length_affects_onset", "length_affects_severity"],
        "disease_tags":[
            "ataxia"
        ]
    },
    {
        "chrom":"chr1",
        "start_hg38":57367044,
        "stop_hg38":57367125,
        "start_hg19":57832716,
        "stop_hg19":57832797,
        "start_t2t":57245936,
        "stop_t2t":57245977,
        "id":"SCA37_DAB1",
        "disease_id":"SCA37",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "AAAAT"
        ],
        "pathogenic_motif_reference_orientation":[
            "GAAAT"
        ],
        "pathogenic_motif_gene_orientation":[
            "ATTTC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[
            "AAAAA"
        ],
        "unknown_motif_gene_orientation":[
            "TTTTT"
        ],
        "disease":"Spinocerebellar Ataxia Type 37",
        "gene":"DAB1",
        "flank_motif":null,
        "locus_structure":"(AAAAT)*(GAAAT)*(AAAAT)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 1 (most isoforms)",
        "benign_min":0.0,
        "benign_max":30.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":31.0,
        "pathogenic_max":75.0,
        "ref_copies":0.0,
        "motif_len":5,
        "age_onset":"Typical: 33-53; Range: 18-64 [@genereviews:NBK541729].",
        "age_onset_min":18,
        "age_onset_max":64,
        "typ_age_onset_min":33.0,
        "typ_age_onset_max":53.0,
        "novel":"novel",
        "mechanism":"GoF",
        "mechanism_detail":"Toxic gain-of-function mechanism in protein, associated with alternative splicing, an RNA switch, and an upregulation of reelin-DAB1 signalling [@omim:615945; @pmid:30284037].",
        "source":[],
        "details":"Pathogenicity only associated with pathogenic motif >30 repeats, flanked by at least 58 repeats of reference motif on either side; reference repeat (AAAAT) can range from 1 to 400 repeats, although typically less than 30 [@genereviews:NBK541729]. The pathogenic motif is unstable, particularly when transmitted by the father [@genereviews:NBK541729].",
        "omim":[
            "615945"
        ],
        "prevalence":null,
        "prevalence_details":"0.20/100,000 specific to Portugal; not yet found in other geographic regions. Founder effect from Iberian Peninsula [@genereviews:NBK541729].",
        "stripy":[
            "DAB1"
        ],
        "gnomad":[
            "DAB1"
        ],
        "genereviews":[
            "NBK541729"
        ],
        "mondo":[
            "0014410"
        ],
        "year":"2017 [@pmid:28686858]",
        "medgen":[
            "855217"
        ],
        "orphanet":[
            "363710"
        ],
        "gard":[
            "12368"
        ],
        "malacard":[
            "SPN283"
        ],
        "webstr_hg38":[
            "1144531"
        ],
        "webstr_hg19":[
            "STR_39393"
        ],
        "tr_gnomad":[
            "TR3445"
        ],
        "disease_description":"Spinocerebellar ataxia type 37 (SCA37) is a subtype of autosomal dominant cerebellar ataxia type 1 (ADCA type 1), characterized by a cerebellar syndrome along with altered vertical eye movements [@mondo:0014410].",
        "locus_tags":["maternal expansion", "paternal_expansion", "motif_affects_onset", "motif_affects_penetrance"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr12",
        "start_hg38":50505002,
        "stop_hg38":50505022,
        "start_hg19":50898785,
        "stop_hg19":50898805,
        "start_t2t":50468096,
        "stop_t2t":50468116,
        "id":"FRA12A_DIP2B",
        "disease_id":"FRA12A",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GGC"
        ],
        "pathogenic_motif_reference_orientation":[
            "GGC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Intellectual developmental disorder, FRA12A type",
        "gene":"DIP2B",
        "flank_motif":null,
        "locus_structure":"(GGC)*",
        "inheritance":[
            "AD"
        ],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":6.0,
        "benign_max":23.0,
        "intermediate_min":139.0,
        "intermediate_max":206.0,
        "pathogenic_min":273.0,
        "pathogenic_max":306.0,
        "ref_copies":7.0,
        "motif_len":3,
        "age_onset":"Typical: 0-1 (small sample size) [@pmid:3742859]. Range: 0-3 [@pmid:4042396].",
        "age_onset_min":0,
        "age_onset_max":3,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Hypermethylation leading to decreased expression, although unmethylated expansion leads to increased expression [@omim:136630; @doi:10.1101/2022.09.12.22279739].",
        "source":[],
        "details":"Repeat ranges reflect affected and unaffected individuals from a cohort study of 70 controls (6-23 repeats), unaffected carriers representing the intermediate alleles (139-206), and affected individuals (273-306) [@pmid:17236128].",
        "omim":[
            "136630"
        ],
        "prevalence":null,
        "prevalence_details":"Appears to occur in those of European ancestry/ethnicity [@omim:136630].",
        "stripy":[
            "DIP2B"
        ],
        "gnomad":[
            "DIP2B"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0007634"
        ],
        "year":"2007 [@pmid:17236128]",
        "medgen":[
            "369613"
        ],
        "orphanet":[],
        "gard":[],
        "malacard":[
            "INT482"
        ],
        "webstr_hg38":[
            "5075695"
        ],
        "webstr_hg19":[
            "Expansion_FRA12A_MR/DIP2B"
        ],
        "tr_gnomad":[
            "TR116656"
        ],
        "disease_description":"...impaired intellectual development with or without other anomalies has been described in patients with over 40% of cells expressing FRA12A [@omim:136630].",
        "locus_tags":[],
        "disease_tags":[]
    },
    {
        "chrom":"chrX",
        "start_hg38":31284557,
        "stop_hg38":31284605,
        "start_hg19":31302674,
        "stop_hg19":31302722,
        "start_t2t":30882695,
        "stop_t2t":30882743,
        "id":"DMD_DMD",
        "disease_id":"DMD",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "TTC"
        ],
        "pathogenic_motif_reference_orientation":[
            "TTC"
        ],
        "pathogenic_motif_gene_orientation":[
            "AAG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Duchenne muscular dystrophy",
        "gene":"DMD",
        "flank_motif":null,
        "locus_structure":"(TTC)*",
        "inheritance":[
            "XR"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 62",
        "benign_min":16.0,
        "benign_max":33.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":59.0,
        "pathogenic_max":82.0,
        "ref_copies":16.7,
        "motif_len":3,
        "age_onset":"Typical: 6-7 (usual disease is 0-3) [@pmid:27417533].",
        "age_onset_min":6,
        "age_onset_max":7,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Functional defect in dystrophin/dystroglycan [@pmid:16969582].",
        "source":[],
        "details":"There is conflicting evidence for the association between this repeat expansion and Duchenne muscular dystrophy. The association was reported in a single family, from which the benign and pathogenic ranges were inferred from affected and unaffected family members [@pmid:27417533]. The population frequency of the proposed pathogenic allele is much higher than expected for a highly penetrant early-onset condition.",
        "omim":[
            "310200"
        ],
        "prevalence":"4.8/100000",
        "prevalence_details":"Believed to be 0 for disease specific to STR expansion. 1/3500-4700 male births (incidence) for overall DMD (one of the most common and severe congenital myopathies) [@genereviews:NBK1119]. 4.8/100,000 prevalence [@pmid:35168641]. DMD repeat locus expansion only identified in one Greek family [@pmid:27417533].",
        "stripy":[
            "DMD"
        ],
        "gnomad":[
            "DMD"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0010679"
        ],
        "year":"2016 [@pmid:27417533]",
        "medgen":[
            "3925"
        ],
        "orphanet":[
            "98896"
        ],
        "gard":[
            "6291"
        ],
        "malacard":[
            "MSC157"
        ],
        "webstr_hg38":[],
        "webstr_hg19":[
            "STR_1545664"
        ],
        "tr_gnomad":[
            "TR167703"
        ],
        "disease_description":"Duchenne muscular dystrophy (DMD) is a neuromuscular disease characterized by rapidly progressive muscle weakness and wasting due to degeneration of skeletal, smooth and cardiac muscle [@mondo:0010679].",
        "locus_tags":["conflicting_evidence", "sparse_evidence"],
        "disease_tags":[]
    },
    {
        "chrom":"chr19",
        "start_hg38":45770204,
        "stop_hg38":45770266,
        "start_hg19":46273462,
        "stop_hg19":46273524,
        "start_t2t":48597739,
        "stop_t2t":48597756,
        "id":"DM1_DMPK",
        "disease_id":"DM1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "CAG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CAG"
        ],
        "pathogenic_motif_gene_orientation":[
            "CTG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Myotonic Dystrophy Type 1",
        "gene":"DMPK",
        "flank_motif":null,
        "locus_structure":"(CAG)*",
        "inheritance":[
            "AD"
        ],
        "type":"3' UTR",
        "location_in_gene":null,
        "benign_min":5.0,
        "benign_max":34.0,
        "intermediate_min":35.0,
        "intermediate_max":49.0,
        "pathogenic_min":50.0,
        "pathogenic_max":1000.0,
        "ref_copies":20.7,
        "motif_len":3,
        "age_onset":"Typical: 10-30 [@genereviews:NBK1165]; Range: 0-74 [@pmid:38454488].",
        "age_onset_min":0,
        "age_onset_max":74,
        "typ_age_onset_min":10.0,
        "typ_age_onset_max":30.0,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"RNA gain-of-function: RNA gelation leading to misregulation of alternative splicing [@pmid:36169768].",
        "source":[],
        "details":"Intermediate alleles (35-49) associated with premutation [@genereviews:NBK1165]. 3%-8% of DM1 expansions contain variant repeats such as CCG and CGG, associated with later onset and milder phenotype [@pmid:32851192]. In another study, interruptions of the CTG repeat with CCG, GGC, CTC or CAG motifs are estimated to occur in 3-11% of DM1 patients [@pmid:35741732].",
        "omim":[
            "160900"
        ],
        "prevalence":"9.27/100000",
        "prevalence_details":"5-20/100,000 [@genereviews:NBK1165]. 0.5-18.1/100,000 [@pmid:29100084]; 6.5/100,000 [@pmid:31159885]. 9.27 cases (95% CI: 4.73-15.21) per 100,000, ranging from 0.37 to 36.29 cases per 100,000 [@pmid:35483324]. Found across ethnicities/ancestries, with population-dependent prevalence [@genereviews:NBK1165].",
        "stripy":[
            "DMPK"
        ],
        "gnomad":[
            "DMPK"
        ],
        "genereviews":[
            "NBK1165"
        ],
        "mondo":[
            "0008056"
        ],
        "year":"1992 [@pmid:1310900]",
        "medgen":[
            "886881"
        ],
        "orphanet":[
            "273"
        ],
        "gard":[
            "8310"
        ],
        "malacard":[
            "MYT021"
        ],
        "webstr_hg38":[
            "5650727"
        ],
        "webstr_hg19":[
            "Expansion_DM1/DMPK"
        ],
        "tr_gnomad":[
            "TR156684"
        ],
        "disease_description":"Steinert disease, also known as myotonic dystrophy type 1, is a muscle disease characterized by myotonia and by multiorgan damage that combines various degrees of muscle weakness, arrhythmia and/or cardiac conduction disorders, cataract, endocrine damage, sleep disorders and baldness [@mondo:0008056].",
        "locus_tags":["somatic_instability", "anticipation", "maternal expansion", "length_affects_onset", "length_affects_phenotype", "length_affects_severity", "motif_affects_instability", "motif_affects_onset", "motif_affects_phenotype", "motif_affects_severity"],
        "disease_tags":["myotonic dystrophy"]
    },
    {
        "chrom":"chr17",
        "start_hg38":80147059,
        "stop_hg38":80147139,
        "start_hg19":78120858,
        "stop_hg19":78120938,
        "start_t2t":81047454,
        "stop_t2t":81047534,
        "id":"RCPS_EIF4A3",
        "disease_id":"RCPS",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "CCTCGCTGTGCCGCTGCCGA"
        ],
        "pathogenic_motif_reference_orientation":[
            "CCTCGCTGTGCCGCTGCCGA"
        ],
        "pathogenic_motif_gene_orientation":[
            "ACAGCGAGGTCGGCAGCGGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Richieri-Costa-Pereira syndrome",
        "gene":"EIF4A3",
        "flank_motif":null,
        "locus_structure":"(CCTCGCTGCGCCGCTGCCGA)*(CCTCGCTGTGCCGCTGCCGA)*",
        "inheritance":[
            "AR"
        ],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":1.0,
        "benign_max":12.0,
        "intermediate_min":13.0,
        "intermediate_max":13.0,
        "pathogenic_min":14.0,
        "pathogenic_max":16.0,
        "ref_copies":null,
        "motif_len":20,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":0.0,
        "typ_age_onset_max":0.0,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"LoF from a hypomorphic allele [@pmid:24360810].",
        "source":[],
        "details":"Complex repeat of 18-20 nucleotides expands to cause diease: disease is found in individuals with 14-16 repeats [@pmid:24360810], while controls have typically 3-12 repeats with as low as 1 repeat [@genereviews:NBK535148; @gnomad:EIF4A3]. Significance of intermediate alleles is unknown [@pmid:29112243].",
        "omim":[
            "268305"
        ],
        "prevalence":null,
        "prevalence_details":"49 cases as of Nov 2023 [@doi:10.1016/j.omsc.2023.100340]. Found in Brazilian families and one unrelated French patient [@mondo:0009998].",
        "stripy":[],
        "gnomad":[
            "EIF4A3"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0009998"
        ],
        "year":"2014 [@pmid:24360810]; syndrome described in 1992 [@pmid:1632438]",
        "medgen":[
            "336581"
        ],
        "orphanet":[
            "3102"
        ],
        "gard":[
            "4718"
        ],
        "malacard":[
            "RBN014"
        ],
        "webstr_hg38":[],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR148462"
        ],
        "disease_description":"Richieri Costa-Pereira syndrome is characterized by short stature, Robin sequence, cleft mandible, pre/postaxial hand anomalies (including hypoplastic thumbs), and clubfoot. It has been described in 14 Brazilian families and in one unrelated French patient. Prominent low set ears and a highly arched palate were also observed. Transmission is autosomal recessive [@mondo:0009998].",
        "locus_tags":[],
        "disease_tags":[]
    },
    {
        "chrom":"chr13",
        "start_hg38":102161577,
        "stop_hg38":102161726,
        "start_hg19":102813927,
        "stop_hg19":102814076,
        "start_t2t":101377640,
        "stop_t2t":101377789,
        "id":"SCA27B_FGF14",
        "disease_id":"SCA27B",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "GAA"
        ],
        "pathogenic_motif_reference_orientation":[
            "GAA"
        ],
        "pathogenic_motif_gene_orientation":[
            "CTT"
        ],
        "benign_motif_reference_orientation":[
            "GAAGGA",
            "GAAGAAGAAGAAGCA",
            "AAGGAG"
        ],
        "benign_motif_gene_orientation":[
            "CCTTCT",
            "CTGCTTCTTCTTCTT",
            "CTCCTT"
        ],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinocerebellar ataxia 27B",
        "gene":"FGF14",
        "flank_motif":null,
        "locus_structure":"(GAA)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "benign_min":8.0,
        "benign_max":179.0,
        "intermediate_min":180.0,
        "intermediate_max":319.0,
        "pathogenic_min":320.0,
        "pathogenic_max":937.0,
        "ref_copies":50.3,
        "motif_len":3,
        "age_onset":"Typical: 42-70; Range: 21-87 [@genereviews:NBK599589; @pmid:39263992].",
        "age_onset_min":21,
        "age_onset_max":87,
        "typ_age_onset_min":42.0,
        "typ_age_onset_max":70.0,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Reduced transcript 2 [@pmid:36516086].",
        "source":[],
        "details":"Higher repeat size is associated with earlier age of onset [@pmid:39263992]. The 250-300 repeats range is linked to incomplete penetrance and >300 repeats with complete penetrance in some studies and resources [@genereviews:NBK599589; @pmid:37399286; @pmid:39227614]. However, our thresholds are taken from suggestions made by Mohren et al upon evaluation of 169 cases and 802 controls; the authors propose lower thresholds based on pathogenic cases of shorter pure repeats [@pmid:39227614]. Additionally, this study suggests that benign motifs may disrupt the formation of secondary structures in DNA/RNA, leading to reduced pathogenicity. Variation in flanking regions appear to correlate with repeat size [@pmid:39227614; @pmid:38937606]. Intermediate alleles make pose as susceptibility factors [@pmid:39227614].",
        "omim":[
            "620174"
        ],
        "prevalence":null,
        "prevalence_details":"Intermediate expansions 1-2% of population, but non-GAA-pure without relation to ataxia [@genereviews:NBK599589]. Found in multiple ethnicities [@pmid:38876750]; diagnosed patients in America, Brazil, Japan, Germany, Spain, Canada, France, Austria and Australia [@genereviews:NBK599589].",
        "stripy":[
            "FGF14"
        ],
        "gnomad":[],
        "genereviews":[
            "NBK599589"
        ],
        "mondo":[
            "0859340"
        ],
        "year":"2023 [@pmid:36493768]",
        "medgen":[
            "1824051"
        ],
        "orphanet":[
            "675216"
        ],
        "gard":[],
        "malacard":[
            "SPN469"
        ],
        "webstr_hg38":[
            "1272528"
        ],
        "webstr_hg19":[],
        "tr_gnomad":[],
        "disease_description":"Late-onset ataxia, may have episodic onset, downbeat nystagmus, vertigo, neuropathy [@pmid:39349043].",
        "locus_tags":["maternal expansion", "length_affects_onset", "length_affects_penetrance","motif_affects_penetrance"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chrX",
        "start_hg38":147912037,
        "stop_hg38":147912111,
        "start_hg19":146993555,
        "stop_hg19":146993629,
        "start_t2t":146176665,
        "stop_t2t":146176769,
        "id":"FXS_FMR1",
        "disease_id":"FXS, FXTAS, POF1",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "CGG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CGG"
        ],
        "pathogenic_motif_gene_orientation":[
            "CGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Fragile X syndrome (FXS), fragile X-associated tremor/ataxia syndrome (FXTAS), and fragile X-associated primary ovarian insufficiency FXPOI/POF1",
        "gene":"FMR1",
        "flank_motif":null,
        "locus_structure":"(CGG)*",
        "inheritance":[
            "XD"
        ],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":5.0,
        "benign_max":44.0,
        "intermediate_min":45.0,
        "intermediate_max":200.0,
        "pathogenic_min":201.0,
        "pathogenic_max":2000.0,
        "ref_copies":20.6667,
        "motif_len":3,
        "age_onset":"Typical: FXS 1 to 'first several years of life', FXTAS 60-65 [@genereviews:NBK1384]; Range: 0 [@uptodate:'Fragile X syndrome: Clinical features and diagnosis in children and adolescents'] - 78 [@pmid:17427188]; detailed description of typical symptom onset and diagnosis available from Arnold et al [@isbn:978-3-031-66932-3].",
        "age_onset_min":0,
        "age_onset_max":78,
        "typ_age_onset_min":1.0,
        "typ_age_onset_max":65.0,
        "novel":"ref",
        "mechanism":"LoF/GoF",
        "mechanism_detail":"Loss of function via transcriptional silencing in FXS, RNA gain of function in FXTAS/FXPOI [@pmid:16205714; @pmid:36169768].",
        "source":[],
        "details":"Intermediate or 'gray zone' occur at 45-54 alleles and may be unstable enough to expand into the premutation range, as well as associate with parkinsonism [@pmid:32463542; @genereviews:NBK1384]. FXTAS/POI occurs at 55-200 repeats, FXS >200, late onset; AGG and CTG interruptions documented [@genereviews:NBK1384; @pmid:29868108].",
        "omim":[
            "300624",
            "300623"
        ],
        "prevalence":"14/100000",
        "prevalence_details":"Incidence of full mutation in males 19/100,000; prevalence 14/100,000 [@genereviews:NBK1384]. Female prevalence 9/100,000 [@pmid:24700618]. Known carrier frequency is approximately 300-500/100,000 but detected was 11/100,000 [@pmid:29100084]. FXS prevalence 1:7000 males, 1:11,000 females; FX premutation carriers 1:290-855 males, 1:148-300 females [@isbn:978-3-031-66932-3]. Found worldwide [@genereviews:NBK1384]. In Thailand, 1 in 600 women carry a premutation, and 1 in 400 carry a 'gray zone' allele [@pmid:39320553].",
        "stripy":[
            "FMR1"
        ],
        "gnomad":[
            "FMR1"
        ],
        "genereviews":[
            "NBK1384"
        ],
        "mondo":[
            "0010383",
            "0010706",
            "0010382"
        ],
        "year":"1992 [@pmid:1605194]; causative gene discovered in 1991 [@pmid:1710175]",
        "medgen":[
            "8912",
            "1644269",
            "333403"
        ],
        "orphanet":[
            "908",
            "642691",
            "93256"
        ],
        "gard":[
            "6464",
            "16806"
        ],
        "malacard":[
            "FRG001",
            "FRG008",
            "PRM405"
        ],
        "webstr_hg38":[
            "885222"
        ],
        "webstr_hg19":[
            "Expansion_FXS/FMR1"
        ],
        "tr_gnomad":[
            "TR173944"
        ],
        "disease_description":"A genetic syndrome caused by mutations in the FMR1 gene which is responsible for the expression of the fragile X mental retardation 1 protein. This protein participates in neural development. This syndrome is manifested with mental, emotional, behavioral, physical, and learning disabilities.; Any primary ovarian failure in which the cause of the disease is a mutation in the FMR1 gene.; Fragile X-associated tremor/ataxia syndrome (FXTAS) is a rare neurodegenerative disorder characterized by adult-onset progressive intention tremor and gait ataxia [@mondo:0010383; @mondo:0010706; @mondo:0010382].",
        "locus_tags":["somatic_instability", "anticipation", "maternal expansion", "length_affects_onset", "length_affects_penetrance", "length_affects_phenotype", "length_affects_severity", "motif_affects_instability"],
        "disease_tags":["phenotypic spectrum",
            "ataxia"
        ]
    },
    {
        "chrom":"chr3",
        "start_hg38":138946020,
        "stop_hg38":138946062,
        "start_hg19":138664862,
        "stop_hg19":138664904,
        "start_t2t":141687014,
        "stop_t2t":141687051,
        "id":"BPES_FOXL2",
        "disease_id":"BPES",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Blepharophimosis, epicanthus inversus, and ptosis",
        "gene":"FOXL2",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "inheritance":[
            "AD", "AR"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "benign_min":14.0,
        "benign_max":14.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":15.0,
        "pathogenic_max":24.0,
        "ref_copies":14.0,
        "motif_len":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":0.0,
        "typ_age_onset_max":0.0,
        "novel":"ref",
        "mechanism":"GoF/LoF",
        "mechanism_detail":"Polyalanine expansion leads to haploinsufficiency, likely due to decreased protein availibility due to mislocalization following nuclear inclusion [@genereviews:NBK1441; @pmid:15591279]",
        "source":[],
        "details":"14 repeats appears highly constrained in humans: homozygous expansions from 14 polyalanines to 19 leads to disease, which can be limited to isolated palpebral defects [@pmid:15591279]. Heterozygous expansions to 24 polyalanines also lead to disease [@pmid:15591279]. Locus start can differ between catalogs, which can affect genotyping.",
        "omim":[
            "110100"
        ],
        "prevalence":"0.3/50000",
        "prevalence_details":"1 in 50,000 births globally for all BPES, with FOXL2 expansions ~30% of pathogenic variants [@genereviews:NBK1441; @genereviews:NBK535148; @pmid:12529855]. Found worldwide, without differences in prevalence based on sex/ethnicity [@genereviews:NBK1441].",
        "stripy":[
            "FOXL2"
        ],
        "gnomad":[
            "FOXL2"
        ],
        "genereviews":[
            "NBK1441"
        ],
        "mondo":[
            "0007201"
        ],
        "year":"2003 [@pmid:12529855]" ,
        "medgen":[
            "66312"
        ],
        "orphanet":[
            "126"
        ],
        "gard":[
            "23"
        ],
        "malacard":[
            "BLP046"
        ],
        "webstr_hg38":[],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR36092"
        ],
        "disease_description":"Blepharophimosis, Ptosis, and Epicanthus Inversus syndrome (BPES) is an ophthalmic disorder characterized by blepharophimosis, ptosis, epicanthus inversus, and telecanthus, that can appear associated with (type I) or without premature ovarian failure (POF) (type II) [@mondo:0007201].",
        "locus_tags":[],
        "disease_tags":[]
    },
    {
        "chrom":"chr9",
        "start_hg38":69037286,
        "stop_hg38":69037304,
        "start_hg19":71652202,
        "stop_hg19":71652220,
        "start_t2t":81210843,
        "stop_t2t":81210861,
        "id":"FRDA_FXN",
        "disease_id":"FRDA",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GAA"
        ],
        "pathogenic_motif_reference_orientation":[
            "GAA"
        ],
        "pathogenic_motif_gene_orientation":[
            "AAG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Friedreich ataxia",
        "gene":"FXN",
        "flank_motif":"(A)16(GAA)n",
        "locus_structure":"(A)*(GAA)*",
        "inheritance":[
            "AR"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "benign_min":5.0,
        "benign_max":33.0,
        "intermediate_min":34.0,
        "intermediate_max":55.0,
        "pathogenic_min":56.0,
        "pathogenic_max":1700.0,
        "ref_copies":6.0,
        "motif_len":3,
        "age_onset":"Typical: 10-15; Range: 2-80 [@genereviews:NBK1281].",
        "age_onset_min":2,
        "age_onset_max":80,
        "typ_age_onset_min":10.0,
        "typ_age_onset_max":15.0,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Loss of function via transcriptional silencing [@pmid:16205714; @pmid:36169768].",
        "source":[
        ],
        "details":"96% of FA patients have biallelic GAA expansions in intron 1 (compared to compound heterozygous with another mutation type), in which the reference allele is conventionally 5-33 repeats [@genereviews:NBK1281]. Intermediate alleles (34-55) are associated with premutations, but may lead to disease as exact pathogenicity/penetrance thresholds have not been demarcated [@genereviews:NBK1281]. The expanded repeats can interrupted either with GAAGAG, GAAGGA, or GAAGAAAA sequences, leading to differential phenotypes [@pmid:11748752]. Allele size is correlated with disease severity and inversely correlated to age of onset, and expansions can reach 1700 repeats [@pmid:8815938].",
        "omim":[
            "229300"
        ],
        "prevalence":"1/50000",
        "prevalence_details":"1/50,000 [@omim:229300; @pmid:29100084]: Known carrier frequency 1000/100,000; observed 421/100,000. Most common inherited ataxia in Europe, the Middle East, India, and North Africa; not documented in Southeast Asia, in sub-Saharan Africa, or among Native Americans [@genereviews:NBK1281].",
        "stripy":[
            "FXN"
        ],
        "gnomad":[
            "FXN"
        ],
        "genereviews":[
            "NBK1281"
        ],
        "mondo":[
            "0100340"
        ],
        "year":"1996 [@pmid:8596916]",
        "medgen":[
            "383962"
        ],
        "orphanet":[
            "95"
        ],
        "gard":[
            "6468"
        ],
        "malacard":[
            "FRD001"
        ],
        "webstr_hg38":[
            "1509872"
        ],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR93516"
        ],
        "disease_description":"Any Friedreich ataxia in which the cause of the disease is a mutation in the FXN gene [@mondo:0100340].",
        "locus_tags":["somatic_instability", "maternal expansion", "length_affects_onset", "length_affects_phenotype", "motif_affects_instability", "motif_affects_onset", "motif_affects_penetrance"],
        "disease_tags":[
            "ataxia"
        ]
    },
    {
        "chrom":"chr19",
        "start_hg38":14496041,
        "stop_hg38":14496074,
        "start_hg19":14606853,
        "stop_hg19":14606886,
        "start_t2t":14622656,
        "stop_t2t":14622702,
        "id":"OPDM2_GIPC1",
        "disease_id":"OPDM2",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "CCG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CCG"
        ],
        "pathogenic_motif_gene_orientation":[
            "CGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Oculopharyngodistal myopathy",
        "gene":"GIPC1",
        "flank_motif":null,
        "locus_structure":"(CCG)*",
        "inheritance":[
            "AD"
        ],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":0.0,
        "benign_max":32.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":73.0,
        "pathogenic_max":164.0,
        "ref_copies":14.7,
        "motif_len":3,
        "age_onset":"Typical: 20-34 [@pmid:32413282]; Range: 14 [@pmid:32413282] - 70 [@pmid:33374016].",
        "age_onset_min":14,
        "age_onset_max":70,
        "typ_age_onset_min":20.0,
        "typ_age_onset_max":34.0,
        "novel":"ref",
        "mechanism":"LoF/GoF?",
        "mechanism_detail":"RNA mediated toxicity hypothesized [@omim:618940], still unknown [@pmid:36169768].",
        "source":[],
        "details":"Benign repeats range from absent [@gnomad:GIPC1] to 32 [@genereviews:NBK535148], while pathogenic alleles range from 73-164 repeats [@pmid:38876750; @genereviews:NBK535148]. Intermediate alleles have undetermined significance but may represent a phenotypic spectrum [@pmid:32413282]. Interruptions documented: CGA [@pmid:35245110]. Interruptions proposed but not confirmed in primary literature: TCG/CCT/TTG [@pmid:38467784].",
        "omim":[
            "618940"
        ],
        "prevalence":null,
        "prevalence_details":"Population dependent; presumed rare. Predominantly found in individuals of East Asian ancestry [@pmid:38876750].",
        "stripy":[
            "GIPC1"
        ],
        "gnomad":[
            "GIPC1"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0030134"
        ],
        "year":"2020 [@pmid:32413282]",
        "medgen":[
            "1718769"
        ],
        "orphanet":[],
        "gard":[
            "16397"
        ],
        "malacard":[
            "OCL080"
        ],
        "webstr_hg38":[
            "5626440"
        ],
        "webstr_hg19":[
            "STR_668861"
        ],
        "tr_gnomad":[
            "TR154638"
        ],
        "disease_description":"Ptosis, external ophthalmoplegia, facial weakness, and pharyngeal and distal limb weakness [@pmid:38876750]; Slowly progressive distal weakness, ophthalmoplegia, facial and bulbar weakness [@pmid:39349043].",
        "locus_tags":["length_affects_onset", "length_affects_severity"],
        "disease_tags":["Oculopharyngodistal myopathy"]
    },
    {
        "chrom":"chr2",
        "start_hg38":190880873,
        "stop_hg38":190880920,
        "start_hg19":191745599,
        "stop_hg19":191745646,
        "start_t2t":191369983,
        "stop_t2t":191370024,
        "id":"GDPAG_GLS",
        "disease_id":"GDPAG",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCA"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCA"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Glutaminase deficiency",
        "gene":"GLS",
        "flank_motif":null,
        "locus_structure":"(GCA)*",
        "inheritance":[
            "AR"
        ],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":5.0,
        "benign_max":38.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":680.0,
        "pathogenic_max":1500.0,
        "ref_copies":16.0,
        "motif_len":3,
        "age_onset":"Early childhood (2-4) [@pmid:30970188; @pmid:35913761].",
        "age_onset_min":2,
        "age_onset_max":4,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Change in histone modification decreases transcription [@omim:618412].",
        "source":[],
        "details":"Pathogenic range from 3 unrelated probands; benign range inferred from mutation data [@genereviews:NBK535148]. Disease cases can be caused by homozygosity or compund heterozygotes [@omim:618412].",
        "omim":[
            "618412"
        ],
        "prevalence":null,
        "prevalence_details":"As of 2019, only 7 cases total of GLS deficiency, including non-repeat. Identified unrelated patients have been Canadian [@pmid:30970188], Kurdish (Turkey) [@pmid:35913761], and US-American (Northern European/Native American descent [@pmid:35913761].",
        "stripy":[
            "GLS"
        ],
        "gnomad":[
            "GLS"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0600001"
        ],
        "year":"2019 [@pmid:30970188]",
        "medgen":[
            "987241"
        ],
        "orphanet":[
            "557056"
        ],
        "gard":[],
        "malacard":[
            "SPS235"
        ],
        "webstr_hg38":[
            "333878",
            "5494902"
        ],
        "webstr_hg19":[
            "STR_803303"
        ],
        "tr_gnomad":[
            "TR24838"
        ],
        "disease_description":"Glutaminase deficiency is characterized by refractory seizures, respiratory failure, brain abnormalities and death in the neonatal period, though milder cases with spastic ataxia-dysarthria have also been reported. This condition is caused by mutations in the glutaminase (GLS) gene [@mondo:0600001].",
        "locus_tags":["sparse_evidence"],
        "disease_tags":[]
    },
    {
        "chrom":"chr7",
        "start_hg38":27199924,
        "stop_hg38":27199966,
        "start_hg19":27239543,
        "stop_hg19":27239585,
        "start_t2t":27335920,
        "stop_t2t":27335951,
        "id":"HFG_HOXA13-I",
        "disease_id":"HFG-I",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Hand-foot-genital syndrome 1",
        "gene":"HOXA13",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "benign_min":14.0,
        "benign_max":14.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":22.0,
        "pathogenic_max":22.0,
        "ref_copies":14.0,
        "motif_len":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Polyalanine expansions leading to haploinsufficiency [@genereviews:NBK1423]",
        "source":[],
        "details":"Anticipation does not occur, and expansions appear fully penetrant [@genereviews:NBK1423].",
        "omim":[
            "140000"
        ],
        "prevalence":null,
        "prevalence_details":"Extremely rare, published cases generally European ancestry or unknown [@pmid:15385446; @pmid:17935235; @genereviews:NBK1423].",
        "stripy":[
            "HOXA13_1"
        ],
        "gnomad":[
            "HOXA13_1"
        ],
        "genereviews":[
            "NBK1423"
        ],
        "mondo":[
            "0007698"
        ],
        "year":"2004 [@pmid:15385446]",
        "medgen":[
            "331103"
        ],
        "orphanet":[
            "2438"
        ],
        "gard":[
            "2594"
        ],
        "malacard":[
            "HND004"
        ],
        "webstr_hg38":[
            "5679832"
        ],
        "webstr_hg19":[
            "STR_1311037"
        ],
        "tr_gnomad":[
            "TR74138"
        ],
        "disease_description":"Hand-foot-genital syndrome (HFGS) is a very rare multiple congenital abnormality syndrome characterized by distal limb malformations and urogenital defects [@mondo:0007698].",
        "locus_tags":[],
        "disease_tags":["Hand-foot-genital syndrome"]
    },
    {
        "chrom":"chr7",
        "start_hg38":27199825,
        "stop_hg38":27199861,
        "start_hg19":27239444,
        "stop_hg19":27239480,
        "start_t2t":27335914,
        "stop_t2t":27335954,
        "id":"HFG_HOXA13-II",
        "disease_id":"HFG-II",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Hand-foot-genital syndrome 2",
        "gene":"HOXA13",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "benign_min":12.0,
        "benign_max":12.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":18.0,
        "pathogenic_max":18.0,
        "ref_copies":12.0,
        "motif_len":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Polyalanine expansions leading to haploinsufficiency [@genereviews:NBK1423]",
        "source":[],
        "details":"Anticipation does not occur, and expansions appear fully penetrant [@genereviews:NBK1423].",
        "omim":[
            "140000"
        ],
        "prevalence":null,
        "prevalence_details":"Extremely rare, published cases generally European ancestry or unknown [@pmid:15385446; @pmid:17935235; @genereviews:NBK1423].",
        "stripy":[
            "HOXA13_2"
        ],
        "gnomad":[
            "HOXA13_2"
        ],
        "genereviews":[
            "NBK1423"
        ],
        "mondo":[
            "0007698"
        ],
        "year":"2003 [@pmid:12676922]",
        "medgen":[
            "331103"
        ],
        "orphanet":[
            "2438"
        ],
        "gard":[
            "2594"
        ],
        "malacard":[
            "HND004"
        ],
        "webstr_hg38":[
            "5679831"
        ],
        "webstr_hg19":[
            "STR_1311036"
        ],
        "tr_gnomad":[
            "TR74137"
        ],
        "disease_description":"Hand-foot-genital syndrome (HFGS) is a very rare multiple congenital abnormality syndrome characterized by distal limb malformations and urogenital defects [@mondo:0007698].",
        "locus_tags":[],
        "disease_tags":["Hand-foot-genital syndrome"]
    },
    {
        "chrom":"chr7",
        "start_hg38":27199678,
        "stop_hg38":27199732,
        "start_hg19":27239297,
        "stop_hg19":27239351,
        "start_t2t":27335815,
        "stop_t2t":27335849,
        "id":"HFG_HOXA13-III",
        "disease_id":"HFG-III",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Hand-foot-genital syndrome 3",
        "gene":"HOXA13",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "benign_min":8.0,
        "benign_max":18.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":22.0,
        "pathogenic_max":32.0,
        "ref_copies":18.0,
        "motif_len":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Polyalanine expansions leading to haploinsufficiency [@genereviews:NBK1423]",
        "source":[],
        "details":"Anticipation does not occur, and expansions appear fully penetrant; it is unknown if contractions also lead to phenotypic variation [@genereviews:NBK1423].",
        "omim":[
            "140000"
        ],
        "prevalence":null,
        "prevalence_details":"Extremely rare, published cases generally European ancestry or unknown [@pmid:15385446; @pmid:17935235; @genereviews:NBK1423].",
        "stripy":[
            "HOXA13_3"
        ],
        "gnomad":[
            "HOXA13_3"
        ],
        "genereviews":[
            "NBK1423"
        ],
        "mondo":[
            "0007698"
        ],
        "year":"2000 [@pmid:10839976]",
        "medgen":[
            "331103"
        ],
        "orphanet":[
            "2438"
        ],
        "gard":[
            "2594"
        ],
        "malacard":[
            "HND004"
        ],
        "webstr_hg38":[
            "1365344"
        ],
        "webstr_hg19":[
            "STR_1311035"
        ],
        "tr_gnomad":[
            "TR74136"
        ],
        "disease_description":"Hand-foot-genital syndrome (HFGS) is a very rare multiple congenital abnormality syndrome characterized by distal limb malformations and urogenital defects [@mondo:0007698].",
        "locus_tags":[],
        "disease_tags":["Hand-foot-genital syndrome"]
    },
    {
        "chrom":"chr2",
        "start_hg38":176093058,
        "stop_hg38":176093103,
        "start_hg19":176957786,
        "stop_hg19":176957831,
        "start_t2t":176581179,
        "stop_t2t":176581220,
        "id":"SD5_HOXD13",
        "disease_id":"SD5",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Syndactyly",
        "gene":"HOXD13",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "benign_min":15.0,
        "benign_max":15.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":22.0,
        "pathogenic_max":23.0,
        "ref_copies":14.0,
        "motif_len":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Polyalanine expansion leading to GoF [@pmid:38467784]",
        "source":[],
        "details":"Benign alleles are highly conserved to be 15 repeats, with disease observed in individuals with 22-23 repeats [@pmid:8614804; @pmid:22406499] as well as in individuals with 8-11 repeats [@genereviews:NBK535148].",
        "omim":[
            "186000"
        ],
        "prevalence":null,
        "prevalence_details":"Syndactyly is found across dozens of unrelated families worldwide [@pmid:24038517]. However, syndactyly-5 specific to STR expansion has been found in 3 individuals [@genereviews:NBK535148].",
        "stripy":[
            "HOXD13"
        ],
        "gnomad":[
            "HOXD13"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0008513"
        ],
        "year":"1996 [@pmid:8614804]",
        "medgen":[
            "1809573"
        ],
        "orphanet":[
            "295195"
        ],
        "gard":[
            "17358"
        ],
        "malacard":[
            "SYN084"
        ],
        "webstr_hg38":[
            "5486677"
        ],
        "webstr_hg19":[
            "STR_796395"
        ],
        "tr_gnomad":[
            "TR24032"
        ],
        "disease_description":"Synpolydactyly (SPD), or syndactyly type II, is defined as a connection between the middle and ring fingers and fourth and fifth toes, variably associated with postaxial polydactyly in the same digits. Minor local anomalies and various metacarpal or metatarsal abnormalities may be present [@omim:186000].",
        "locus_tags":["contraction", "sparse_evidence"],
        "disease_tags":[]
    },
    {
        "chrom":"chr4",
        "start_hg38":3074877,
        "stop_hg38":3074940,
        "start_hg19":3076604,
        "stop_hg19":3076667,
        "start_t2t":3073604,
        "stop_t2t":3073694,
        "id":"HD_HTT",
        "disease_id":"HD",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "CAG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CAG"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Huntington disease",
        "gene":"HTT",
        "flank_motif":"(CAG)nCAACAG(CCG)12",
        "locus_structure":"(CAG)*CAACAG(CCG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "benign_min":6.0,
        "benign_max":26.0,
        "intermediate_min":27.0,
        "intermediate_max":39.0,
        "pathogenic_min":40.0,
        "pathogenic_max":250.0,
        "ref_copies":21.3,
        "motif_len":3,
        "age_onset":"Typical: 35-44 [@genereviews:NBK1305]; Range: 1-85 [@pmid:39441074; @pmid:21171977].",
        "age_onset_min":1,
        "age_onset_max":85,
        "typ_age_onset_min":35.0,
        "typ_age_onset_max":44.0,
        "novel":"ref",
        "mechanism":"GoF/LoF",
        "mechanism_detail":"While the primary pathogenic mechanism is gain of function of the protein product, pathogenesis is complex and multifactorial [@pmid:27940602].",
        "source":[],
        "details":"27-35 motifs are unstable/premutations, while 36-39 motifs are associated with reduced penetrance. >60 motifs assocated with onset age <20 years [@genereviews:NBK1305]. Only CAG expansions are considered pathogenic, but interruptions impact pathogenicity (e.g. CAA) [@pmid:35245110]. Only fathers with premutations are considered at risk of transmitting pathogenic alleles [@mpid:19507258].",
        "omim":[
            "143100"
        ],
        "prevalence":"1/10000",
        "prevalence_details":"6.5-15/100,000 [@pmid:29100084]. 9.71-17:100,000 (European) vs. 0.1-2/100,000 (African), as many as 1 in 400 have reduced penetrance (0.2-2% for 36-38 CAG) HTT alleles [@genereviews:NBK1305]. Found across ethnicities/ancestries, with population-dependent prevalence [@genereviews:NBK1305].",
        "stripy":[
            "HTT"
        ],
        "gnomad":[
            "HTT"
        ],
        "genereviews":[
            "NBK1305"
        ],
        "mondo":[
            "0007739"
        ],
        "year":"1993 [@pmid:8458085]",
        "medgen":[
            "5654"
        ],
        "orphanet":[
            "399"
        ],
        "gard":[
            "6677"
        ],
        "malacard":[
            "HNT016"
        ],
        "webstr_hg38":[
            "4701738",
            "86468",
            "86467"
        ],
        "webstr_hg19":[
            "Expansion_HD/HTT"
        ],
        "tr_gnomad":[
            "TR40017",
            "TR40018"
        ],
        "disease_description":"Huntington disease (HD) is a rare neurodegenerative disorder of the central nervous system characterized by unwanted choreatic movements, behavioral and psychiatric disturbances and dementia [@mondo:0007739].",
        "locus_tags":["somatic_instability", "anticipation", "paternal_expansion", "length_affects_onset", "length_affects_penetrance", "length_affects_phenotype", "length_affects_severity", "motif_affects_instability", "motif_affects_onset", "motif_affects_penetrance"],
        "disease_tags":[]
    },
    {
        "chrom":"chr16",
        "start_hg38":87604283,
        "stop_hg38":87604329,
        "start_hg19":87637889,
        "stop_hg19":87637935,
        "start_t2t":93675724,
        "stop_t2t":93675776,
        "id":"HDL2_JPH3",
        "disease_id":"HDL2",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "CTG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CTG"
        ],
        "pathogenic_motif_gene_orientation":[
            "CTG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Huntington disease-like 2",
        "gene":"JPH3",
        "flank_motif":null,
        "locus_structure":"(CTG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 2",
        "benign_min":6.0,
        "benign_max":28.0,
        "intermediate_min":29.0,
        "intermediate_max":39.0,
        "pathogenic_min":40.0,
        "pathogenic_max":60.0,
        "ref_copies":15.6667,
        "motif_len":3,
        "age_onset":"Typical: 30-52; Range: 12-66 [@genereviews:NBK1529].",
        "age_onset_min":12,
        "age_onset_max":66,
        "typ_age_onset_min":30.0,
        "typ_age_onset_max":52.0,
        "novel":"ref",
        "mechanism":"LoF/GoF",
        "mechanism_detail":"Non-mutually exclusive mechanisms include loss of function from RNA sequestration and gain of function from toxic transcripts and increased protein expression [@genereviews:NBK1529]",
        "source":[],
        "details":"Intermediate alleles (29-39) may either be premutations or associated with reduced penetrance; the longest pathogenic expansion (40+ motifs) to date is 60 repeats [@genereviews:NBK1529]",
        "omim":[
            "606438"
        ],
        "prevalence":null,
        "prevalence_details":"<1/1,000,000 [@orphanet:98934]. Largely in individuals of African ancestry [@genereviews:NBK1529].",
        "stripy":[
            "JPH3"
        ],
        "gnomad":[
            "JPH3"
        ],
        "genereviews":[
            "NBK1529"
        ],
        "mondo":[
            "0011671"
        ],
        "year":"2001 [@pmid:11694876]",
        "medgen":[
            "341120"
        ],
        "orphanet":[
            "98934"
        ],
        "gard":[
            "16874"
        ],
        "malacard":[
            "HNT004"
        ],
        "webstr_hg38":[
            "828516",
            "5987878"
        ],
        "webstr_hg19":[
            "Expansion_HDL2/JPH3"
        ],
        "tr_gnomad":[
            "TR143309"
        ],
        "disease_description":"Huntington disease-like 2 (HDL2) is a severe neurodegenerative disorder considered part of the neuroacanthocytosis syndromes characterized by a triad of movement, psychiatric, and cognitive abnormalities [@mondo:0011671].",
        "locus_tags":["somatic_instability", "length_affects_phenotype", "length_affects_onset", "length_affects_penetrance", "length_affects_severity"],
        "disease_tags":[]
    },
    {
        "chrom":"chr8",
        "start_hg38":104588972,
        "stop_hg38":104588999,
        "start_hg19":105601200,
        "stop_hg19":105601227,
        "start_t2t":105716410,
        "stop_t2t":105716441,
        "id":"OPDM1_LRP12",
        "disease_id":"OPDM1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "CGC"
        ],
        "pathogenic_motif_reference_orientation":[
            "CGC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Oculopharyngodistal myopathy type 1",
        "gene":"LRP12",
        "flank_motif":null,
        "locus_structure":"(CGC)*",
        "inheritance":[
            "AD"
        ],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":13.0,
        "benign_max":45.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":85.0,
        "pathogenic_max":289.0,
        "ref_copies":11.7,
        "motif_len":3,
        "age_onset":"Typical: 31-51 [@pmid:34047774]; Range: 7-66 [@pmid:2124290].",
        "age_onset_min":7,
        "age_onset_max":66,
        "typ_age_onset_min":31.0,
        "typ_age_onset_max":51.0,
        "novel":"ref",
        "mechanism":"GoF?",
        "mechanism_detail":"RNA mediated toxicity hypothesized [@omim:164310]; may involve RAN translation [@pmid:38467784].",
        "source":[],
        "details":"Benign range (13-45) inferred from cohort data, but pathogenic range isn't yet fully understood [@genereviews:NBK535148]. In a cohort of 65 patients from 59 families, alleles ranged from 85-289 repeats, with an inverse relationship between size and age of onset [@pmid:34047774]. Inherited peripheral neuropathy (IPN) may be associated with shorter expansions [@pmid:39013564]. Interruptions seen: ACG, CCA [@pmid:35245110].",
        "omim":[
            "164310"
        ],
        "prevalence":null,
        "prevalence_details":"Population dependent; unknown percentage of LRP12 pathogenic variants. Typically East Asian ancestry [@pmid:38876750]; potentially most frequent cause of OPDM in Japan [@pmid:34047774].",
        "stripy":[
            "LRP12"
        ],
        "gnomad":[
            "LRP12"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0020793"
        ],
        "year":"2019 [@pmid:31332380]",
        "medgen":[
            "1684682"
        ],
        "orphanet":[
            "98897"
        ],
        "gard":[
            "15097"
        ],
        "malacard":[
            "OCL076"
        ],
        "webstr_hg38":[
            "1082178",
            "4874587"
        ],
        "webstr_hg19":[
            "STR_1441036"
        ],
        "tr_gnomad":[
            "TR88348"
        ],
        "disease_description":"Adult-onset ptosis, dysphagia [@pmid:39349043]; External ophthalmoplegia, facial weakness, pharyngeal, and distal limb weakness [@pmid:38876750]; May be slight male predominance [@pmid:34047774].",
        "locus_tags":["somatic_instability", "anticipation", "length_affects_onset"],
        "disease_tags":["Oculopharyngodistal myopathy"]
    },
    {
        "chrom":"chr5",
        "start_hg38":10356339,
        "stop_hg38":10356411,
        "start_hg19":10356451,
        "stop_hg19":10356523,
        "start_t2t":10295521,
        "stop_t2t":10295593,
        "id":"FAME3_MARCHF6",
        "disease_id":"FAME3",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "TTTTA"
        ],
        "pathogenic_motif_reference_orientation":[
            "TTTCA"
        ],
        "pathogenic_motif_gene_orientation":[
            "ATTTC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[
            "ATGTT",
            "TAGTT",
            "TTTTG",
            "TTTTT"
        ],
        "unknown_motif_gene_orientation":[
            "ATGTT",
            "AGTTT",
            "GTTTT",
            "TTTTT"
        ],
        "disease":"Familial adult myoclonic epilepsy type 3",
        "gene":"MARCHF6",
        "flank_motif":null,
        "locus_structure":"(TTTTA)*(TTTCA)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "benign_min":null,
        "benign_max":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":791.0,
        "pathogenic_max":1035.0,
        "ref_copies":14.8,
        "motif_len":5,
        "age_onset":"Typical: 24-41 based on one 76 member pedigree [@pmid:19616813]; Range: 10 [@omim:613608] - 46 [@pmid:31664039].",
        "age_onset_min":10,
        "age_onset_max":46,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"novel",
        "mechanism":"Unknown",
        "mechanism_detail":"Noted as unknown in literature [@omim:613608].",
        "source":[],
        "details":"Healthy controls do not have pathogenic allele (TTTCA), but do have 9-20 benign motifs (TTTTA) [@genereviews:NBK535148]. Alleles from six probands spanned from 791-1035 repeats; an inverse relationship between allele size and age of onset was noted [@pmid:31664039].",
        "omim":[
            "613608"
        ],
        "prevalence":null,
        "prevalence_details":"Overall FAME prevalence is < 1/35,000; MARCHF6-caused much smaller. Most cases have European ancestry [@pmid:38876750].",
        "stripy":[
            "MARCHF6"
        ],
        "gnomad":[
            "MARCHF6"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0013322"
        ],
        "year":"2019 [@pmid:31664039]",
        "medgen":[
            "462210"
        ],
        "orphanet":[
            "86814"
        ],
        "gard":[
            "18084"
        ],
        "malacard":[
            "EPL053"
        ],
        "webstr_hg38":[
            "5994579"
        ],
        "webstr_hg19":[
            "STR_1116660"
        ],
        "tr_gnomad":[
            "TR51895"
        ],
        "disease_description":"Cortical tremor, seizures with generalised motor (tonic-clonic) onset [@pmid:38876750]; Adult-onset cortical tremor with epilepsy [@pmid:39349043].",
        "locus_tags":["somatic_instability", "motif_affects_onset", "motif_affects_penetrance", "motif_affects_severity"],
        "disease_tags":["Familial adult myoclonic epilepsy"]
    },
    {
        "chrom":"chr1",
        "start_hg38":155188487,
        "stop_hg38":155192239,
        "start_hg19":155160963,
        "stop_hg19":155162030,
        "start_t2t":154328103,
        "stop_t2t":154330802,
        "id":"ADTKD_MUC1",
        "disease_id":"ADTKD",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
          "C"
          ],
        "pathogenic_motif_reference_orientation":[
            "C"
          ],
        "pathogenic_motif_gene_orientation":[
            "C"
          ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Autosomal dominant tubulointerstitial kidney disease",
        "gene":"MUC1",
        "flank_motif":null,
        "locus_structure":"(C)*",
        "inheritance":[
            "AD"
          ],
        "type":"Coding",
        "location_in_gene":"Exon 2",
        "benign_min":7.0,
        "benign_max":7.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":8.0,
        "pathogenic_max":8.0,
        "ref_copies":null,
        "motif_len":1.0,
        "age_onset":"",
        "age_onset_min":20,
        "age_onset_max":70,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Toxic protein product accumulates in kidneys [@genereviews:NBK153723]",
        "source":[],
        "details":"Disease is caused by duplicated cytosine in a heptanucleotide cytosine tract within one copy of a 20-125 copy number VNTR; the specific VNTR involved varies by family but is consistent within a family [@genereviews:NBK535148]. This VNTR is particularly difficult to genotype [@pmid:23396133].",
          "omim":[
            "174000"],
        "prevalence":"2.5/1000000",
        "prevalence_details":"Disease is affected 1-4/1,000,000 (likely an underestimate due to unremarkable findings); repeat expansion responsibile for 95% of disease [@genereviews:NBK153723]",
        "stripy":null,
        "gnomad":null,
        "genereviews":["NBK153723"],
        "mondo":[
            "0020726"],
        "year":"2013 [@pmid:23396133]",
        "medgen":[
            "358137"],
        "orphanet":[
         "88949"],
        "gard":[
           "7002"],
        "malacard":["TBL032"],
        "webstr_hg38":[],
        "webstr_hg19":[],
        "tr_gnomad":[],
        "disease_description":"An inherited disorder that causes a gradual loss of kidney function, caused by a mutation in the MUC1 gene that leads to production of an abnormal mucin 1 protein, which deposits in the kidney and leads to slow loss of kidney function [@mondo:0020726].",
        "locus_tags":[],
        "disease_tags":[]
      },
      {
        "chrom":"chr15",
        "start_hg38":156591766,
        "stop_hg38":156591783,
        "start_hg19":156561558,
        "stop_hg19":156561575,
        "start_t2t":155728132,
        "stop_t2t":155728149,
        "id":"NME_NAXE",
        "disease_id":"NME",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
           "GGGCC"],
        "pathogenic_motif_reference_orientation":[
           "GGGCC"],
        "pathogenic_motif_gene_orientation":[
           "GGGCC"],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"NAXE-related mitochondrial encephalopathy",
        "gene":"NAXE",
        "flank_motif":null,
        "locus_structure":"(GGGCC)*",
        "inheritance":[
               "AR"],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":2.0,
        "benign_max":7.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":200.0,
        "pathogenic_max":200.0,
        "ref_copies":null,
        "motif_len":5,
        "age_onset":"Single repeat expansion case had onset at 13 months, while NAXE-related mitochondrial encephalopathy more generally has predominately infantile onset, extending to 20y or older [@pmid:39455596].",
        "age_onset_min":1,
        "age_onset_max":1,
        "typ_age_onset_min":0,
        "typ_age_onset_max":0,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Reduced NAXE expression from expansion in promoter; hypermethylation was detected at and downstream of the repeat sequence in the proband as well as the maternal copy of the expanded allele, which was not present in the maternal normal range allele nor in the controls [@pmid:39455596]",
        "source":[],
        "details":"Benign range (2-7) alleles established by 484 control alleles and validated with orthogonal databases, while single proband had expansion of ~200 repeats inherited from mother via uniparental disomy [@pmid:39455596]. While the repeat expansion is newly reported, other variants in the NAXE gene have previously been associated with mitochondrial encephalopathy.",
        "omim":[
               "617186"
           ],
        "prevalence":null,
        "prevalence_details":"Single proband found in Japanese cohort [@pmid:39455596].",
        "stripy":[],
        "gnomad":[],
        "genereviews":[],
        "mondo":[
               "0020781"
           ],
        "year":"2024 [@pmid:39455596]",
        "medgen":[
               "934642"
           ],
        "orphanet":[
               "555407"
           ],
        "gard":[
               "17991"
           ],
        "malacard":[
               "ENC069"
           ],
        "webstr_hg38":[
               "1184343",
               "6351240"
           ],
        "webstr_hg19":[],
        "tr_gnomad":[
               "TR7952"
           ],
        "disease_description":"Patients with NAXE-related mitochondrial encephalopathy exhibit developmental delay, cognitive regression, altered consciousness, abnormalities in eye movement (including nystagmus), muscle weakness, respiratory failure, seizure, ataxia, and gait disturbance at the age of 1 to 2 years. The disease is characterized by fluctuating symptoms over time, often exacerbated by febrile illness; it is progressive and fatal in the long term [@pmid:39455596].",
        "locus_tags":[],
        "disease_tags":[]
      },


    {
        "chrom":"chr15",
        "start_hg38":22786677,
        "stop_hg38":22786701,
        "start_hg19":23086366,
        "stop_hg19":23086390,
        "start_t2t":20458505,
        "stop_t2t":20458536,
        "id":"ALS1_NIPA1",
        "disease_id":"ALS1",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCG"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCG"
        ],
        "pathogenic_motif_gene_orientation":[
            "CGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Amyotrophic lateral sclerosis",
        "gene":"NIPA1",
        "flank_motif":null,
        "locus_structure":"(GCG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1/Intron 1 depending on transcript",
        "benign_min":6.0,
        "benign_max":10.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":11.0,
        "pathogenic_max":56.0,
        "ref_copies":10.7,
        "motif_len":3,
        "age_onset":"Typical: 44-60 [@pmid:26777436]; Range: 25 [@pmid:22378146] - 77 [@pmid:26777436].",
        "age_onset_min":25,
        "age_onset_max":77,
        "typ_age_onset_min":44.0,
        "typ_age_onset_max":60.0,
        "novel":"ref",
        "mechanism":null,
        "mechanism_detail":null,
        "source":[],
        "details":"Allelic ranges taken from STRipy based on primary literature [@stripy:NIPA1]. Currently proposed as modifier for ALS [@pmid:31286297].",
        "omim":[
            "105400"
        ],
        "prevalence":null,
        "prevalence_details":"2.7-7.4/100,000 for all cases of ALS, NIPA1 + C9orf72 is 0.37% of ALS patients; frequency of NIPA1 expansion in controls is 3.74% [@pmid:31286297]. The NIPA1 expansion is associated with disease globally [@pmid:30342764], but likely unassociated in African probands [@pmid:34179866].",
        "stripy":[
            "NIPA1"
        ],
        "gnomad":[
            "NIPA1"
        ],
        "genereviews":[],
        "mondo":[
            "0007103"
        ],
        "year":"2019 [@pmid:30342764]",
        "medgen":[
            "400169"
        ],
        "orphanet":[
            "282",
            "803"
        ],
        "gard":[
            "5786"
        ],
        "malacard":[
            "FRN044"
        ],
        "webstr_hg38":[
            "5135087"
        ],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR133649"
        ],
        "disease_description":"Amyotrophic lateral sclerosis is a neurodegenerative disorder characterized by the death of motor neurons in the brain, brainstem, and spinal cord, resulting in fatal paralysis. ALS usually begins with asymmetric involvement of the muscles in middle adult life [@omim:105400].",
        "locus_tags":["conflicting_evidence", "proposed_modifier"],
        "disease_tags":[]
    },
    {
        "chrom":"chr20",
        "start_hg38":2652733,
        "stop_hg38":2652757,
        "start_hg19":2633379,
        "stop_hg19":2633403,
        "start_t2t":2683200,
        "stop_t2t":2683224,
        "id":"SCA36_NOP56",
        "disease_id":"SCA36",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GGCCTG"
        ],
        "pathogenic_motif_reference_orientation":[
            "GGCCTG"
        ],
        "pathogenic_motif_gene_orientation":[
            "CCTGGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinocerebellar ataxia type 36",
        "gene":"NOP56",
        "flank_motif":"(GGCCTG)n(CGCCTG)3",
        "locus_structure":"(GGCCTG)*(CGCCTG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "benign_min":3.0,
        "benign_max":14.0,
        "intermediate_min":15.0,
        "intermediate_max":649.0,
        "pathogenic_min":650.0,
        "pathogenic_max":2500.0,
        "ref_copies":7.2,
        "motif_len":6,
        "age_onset":"Typical: 40-60 [@pmid:25101480]; Range: 28 [@pmid:37810464] - 67 [@pmid:37332636].",
        "age_onset_min":28,
        "age_onset_max":67,
        "typ_age_onset_min":40.0,
        "typ_age_onset_max":60.0,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Toxic protein gain-of-function, RAN translation [@omim:614153].",
        "source":[],
        "details":"Benign alleles range from 3-14 repeats and pathogenic alleles (650+ repeats) appear fully penetrant; the significance of intermediate alleles has yet to be elucidated [@pmid:25101480]. Interruptions documented: GGCTG, GGCCCTG, GGCCG, and GGCCTTG [@pmid:37051597].",
        "omim":[
            "614153"
        ],
        "prevalence":null,
        "prevalence_details":"Western Japan: 3.6% of all SCA; Costa da Morte region of Spain: 6.3% of all SCA [@pmid:37332636]; US: 0.7% of large undiagnosed ataxia cohort [@pmid:28761930]. Found across ancestries/ethnicities [@omim:614153].",
        "stripy":[
            "NOP56"
        ],
        "gnomad":[
            "NOP56"
        ],
        "genereviews":["NBK535148"],
        "mondo":[
            "0013594"
        ],
        "year":"2011 [@pmid:21683323]",
        "medgen":[
            "483339"
        ],
        "orphanet":[
            "276198"
        ],
        "gard":[
            "12367"
        ],
        "malacard":[
            "SPN265"
        ],
        "webstr_hg38":[
            "6177296",
            "890490"
        ],
        "webstr_hg19":[
            "STR_833720"
        ],
        "tr_gnomad":[
            "TR157810",
            "TR157811"
        ],
        "disease_description":"Spinocerebellar ataxia type 36 (SCA36) is a subtype of autosomal dominant cerebellar ataxia type 1 (ADCA type 1) characterized by gait and limb ataxia, lower limb spasticity, dysarthria, muscle fasiculations, tongue atrophy and hyperreflexia [@mondo:0013594].",
        "locus_tags":["somatic_instability", "length_affects_onset", "length_affects_severity"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr1",
        "start_hg38":149390803,
        "stop_hg38":149390842,
        "start_hg19":145209324,
        "stop_hg19":145209354,
        "start_t2t":148519696,
        "stop_t2t":148519738,
        "id":"NIID_NOTCH2NLC",
        "disease_id":"NIID",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GGC"
        ],
        "pathogenic_motif_reference_orientation":[
            "GGC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Neuronal intranuclear inclusion disease, Alzheimer disease and parkinsonism phenotype",
        "gene":"NOTCH2NLC",
        "flank_motif":null,
        "locus_structure":"(GGC)*",
        "inheritance":[
            "AD"
        ],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":7.0,
        "benign_max":37.0,
        "intermediate_min":38.0,
        "intermediate_max":65.0,
        "pathogenic_min":66.0,
        "pathogenic_max":517.0,
        "ref_copies":13.3,
        "motif_len":3,
        "age_onset":"Typical: 30-70 [@omim:603472]; Range: 10 [@pmid:37090934] - 78 [@pmid:37305750].",
        "age_onset_min":10,
        "age_onset_max":78,
        "typ_age_onset_min":30.0,
        "typ_age_onset_max":70.0,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Polyglutamine expansion; may relate to methylation or RNA pathogenicity [@omim:603472; @pmid:36169768; @pmid:38467784].",
        "source":[],
        "details":"Benign alleles are less than 38 repeats, while pathogenic alleles contain 66+ repeats [@genereviews:NBK535148]. Intermediate alleles may be associated with a phenotypic spectrum, and even pathogenic cases can have variable phenotype [@pmid:39055960; @pmid:39496005]: NOTCH2NLC expansions have been linked Alzheimer's disease and Parkinson's disease, leading to a potential role in NIID-related disorders [@pmid:31178126]. Age of onset inversely related to allele size [@pmid:38377026]. Motif variation in controls: (AGG)(CGG)n(AGG)0-3(CGG)0-2. GGA and AGC interruptions may influence phenotype [@pmid:34718964]. Interruptions documented: GGA, GGG [@pmid:35245110]; ACCGAGAAGATGCCCGCCCTGC interruption proposed but not confirmed [@pmid:38467784]. Detection may be challenging due to parology between genes: C253572.1, NOTCH2, NOTCH2NL, NBPF14, NBPF19.",
        "omim":[
            "603472"
        ],
        "prevalence":null,
        "prevalence_details":">400 patients reported in literature [@pmid:37371433]. Found in individuals of East Asian ancestry [@pmid:38876750].",
        "stripy":[
            "NOTCH2NLC"
        ],
        "gnomad":[
            "NOTCH2NLC"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0011327"
        ],
        "year":"2019 [@pmid:31332380]",
        "medgen":[
            "355075"
        ],
        "orphanet":[
            "2289"
        ],
        "gard":[
            "3971"
        ],
        "malacard":[
            "NRN008"
        ],
        "webstr_hg38":[],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR7525"
        ],
        "disease_description":"Neuronal intranuclear inclusion disease (NIID) is a very rare multisystem neurodegenerative disorder characterized by the presence of eosinophilic intranuclear inclusions in neuronal and glial cells, and neuronal loss [@mondo:0011327].",
        "locus_tags":["somatic_instability", "paternal_expansion", "length_affects_onset", "length_affects_phenotype", "motif_affects_onset", "motif_affects_phenotype"],
        "disease_tags":["phenotypic spectrum"]
    },
    {
        "chrom":"chr10",
        "start_hg38":79826383,
        "stop_hg38":79826404,
        "start_hg19":81586139,
        "stop_hg19":81586160,
        "start_t2t":80695712,
        "stop_t2t":80695748,
        "id":"OPML1_NUTM2B-AS1",
        "disease_id":"OPML1",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GGC"
        ],
        "pathogenic_motif_reference_orientation":[
            "GGC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Oculopharyngeal myopathy with leukoencephalopathy 1",
        "gene":"NUTM2B-AS1",
        "flank_motif":null,
        "locus_structure":"(GGC)*",
        "inheritance":[
            "AD"
        ],
        "type":"lncRNA",
        "location_in_gene":"Exon 1 (noncoding)",
        "benign_min":3.0,
        "benign_max":16.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":161.0,
        "pathogenic_max":700.0,
        "ref_copies":7.0,
        "motif_len":3,
        "age_onset":"15-40 (only characterized in one family) [@pmid:31332380].",
        "age_onset_min":15,
        "age_onset_max":40,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"GoF?",
        "mechanism_detail":"RNA mediated toxicity hypothesized, overall mechanism unknown [@omim:618637; @pmid:36169768].",
        "source":[],
        "details":"Benign range (3-16 repeats) established in 1000 controls, studied alongside pathogenic probands of up to 700 repeats [@pmid:31332380]. Pathogenicity occurs at repeats as short as 161 motifs [@pmid:38159879; @pmid:37923380], while intermediate alleles may correlate to milder phenotypes [@pmid:38159879]. Alt transcript in opposite direction: LOC642361.",
        "omim":[
            "618637"
        ],
        "prevalence":null,
        "prevalence_details":"Rare, found in individuals of East Asian ancestry [@pmid:38876750].",
        "stripy":[
            "NUTM2B-AS1"
        ],
        "gnomad":[
            "NUTM2B-AS1"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0032843"
        ],
        "year":"2019 [@pmid:31332380]",
        "medgen":[
            "1684701"
        ],
        "orphanet":[],
        "gard":[],
        "malacard":[
            "OCL077"
        ],
        "webstr_hg38":[],
        "webstr_hg19":[
            "STR_173942"
        ],
        "tr_gnomad":[
            "TR102881"
        ],
        "disease_description":"Oculopharyngodistal myopathy and white matter abnormalities [@pmid:38876750]; Ptosis, ophthalmoplegia, dysphagia, dysarthria [@pmid:39349043].",
        "locus_tags":["sparse_evidence", "length_affects_severity", "length_affects_phenotype"],
        "disease_tags":[]
    },
    {
        "chrom":"chr14",
        "start_hg38":23321472,
        "stop_hg38":23321502,
        "start_hg19":23790681,
        "stop_hg19":23790711,
        "start_t2t":17522488,
        "stop_t2t":17522518,
        "id":"OPMD_PABPN1",
        "disease_id":"OPMD",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Oculopharyngeal muscular dystrophy",
        "gene":"PABPN1",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "inheritance":[
            "AD", "AR"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "benign_min":10.0,
        "benign_max":10.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":11.0,
        "pathogenic_max":18.0,
        "ref_copies":7.0,
        "motif_len":3,
        "age_onset":"Typical: 40-59 [@pmid:37519616]; Range: 20-79 [@pmid:35112761].",
        "age_onset_min":20,
        "age_onset_max":79,
        "typ_age_onset_min":40.0,
        "typ_age_onset_max":59.0,
        "novel":"ref",
        "mechanism":"GoF/LoF",
        "mechanism_detail":"Polyalanine expansions leading to cellular toxicity (loss of function) as well as abnormal aggregation and inefficient protein degradation, which may impact mRNA processing [@genereviews:NBK1126].",
        "source":[],
        "details":"Disease is autosomal dominant when an expansion of 11 motifs is in the first exon of PABPN1 (90% of cases), and autosomal recessive when both alleles are at least 11 motifs; age of onset is inverse to allele size [@genereviews:NBK1126]. Most known patients have (GCG)+, but GCN or any polyalanine may be pathogenic.[@genereviews:NBK1126]",
        "omim":[
            "164300"
        ],
        "prevalence":"1/100000",
        "prevalence_details":"1/100,000 (population specific) [@pmid:29100084]. Frequency of GCN[11] alleles is 1-2% of North America/Europe/Japan [@genereviews:NBK1126]. Disease is found worldwide, in more than 30 countries [@genereviews:NBK1126].",
        "stripy":[
            "PABPN1"
        ],
        "gnomad":[
            "PABPN1"
        ],
        "genereviews":[
            "NBK1126"
        ],
        "mondo":[
            "0958176"
        ],
        "year":"1998 [@pmid:9462747]",
        "medgen":[
            "1054618"
        ],
        "orphanet":[
            "270"
        ],
        "gard":[
            "7245"
        ],
        "malacard":[
            "OCL088"
        ],
        "webstr_hg38":[
            "1442709",
            "5271481"
        ],
        "webstr_hg19":[
            "Expansion_OPMD/PAPBN1"
        ],
        "tr_gnomad":[
            "TR128439"
        ],
        "disease_description":"Ptosis and dysphagia [@pmid:39349043]; facial weakness, ptosis [@pmid:38876750].",
        "locus_tags":["length_affects_onset", "length_affects_severity"],
        "disease_tags":[]
    },
    {
        "chrom":"chr4",
        "start_hg38":41745972,
        "stop_hg38":41746032,
        "start_hg19":41747989,
        "stop_hg19":41748049,
        "start_t2t":41719745,
        "stop_t2t":41719805,
        "id":"CCHS_PHOX2B",
        "disease_id":"CCHS",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Congenital central hypoventilation syndrome",
        "gene":"PHOX2B",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 3",
        "benign_min":9.0,
        "benign_max":20.0,
        "intermediate_min":21.0,
        "intermediate_max":25.0,
        "pathogenic_min":26.0,
        "pathogenic_max":33.0,
        "ref_copies":15.7,
        "motif_len":3,
        "age_onset":"Typical: 0-2 [@genereviews:NBK1427; @pmid:15121777]; Range: 0-36 [@pmid:16873766].",
        "age_onset_min":0,
        "age_onset_max":36,
        "typ_age_onset_min":0.0,
        "typ_age_onset_max":2.0,
        "novel":"ref",
        "mechanism":"LoF/GoF",
        "mechanism_detail":"Polyalanine expansion leading to loss or gain of function, dependent on altered protein product [@pmid:38467784; @genereviews:NBK1427]. Correlation between length and reduced transcriptional activity [@pmid:15888479].",
        "source":[],
        "details":"Alleles of 24 repeats (and sometimes 25 repeats) correspond to delayed disease onset and/or milder phenotype; alleles above benign range (9-20 repeats) and below the pathogenic range (26-33 repeats) have uncertain significance [@genereviews:NBK1427].",
        "omim":[
            "209880"
        ],
        "prevalence":null,
        "prevalence_details":"Incidence is 1:148000-200000 births (Estimated, may include mild/undiagnosed or be overestimated globally) [@genereviews:NBK1427]. Rare, but reported worldwide [@pmid:15121777].",
        "stripy":[
            "PHOX2B"
        ],
        "gnomad":[
            "PHOX2B"
        ],
        "genereviews":[
            "NBK1427"
        ],
        "mondo":[
            "0800026"
        ],
        "year":"2003 [@pmid:12640453]",
        "medgen":[
            "1794285"
        ],
        "orphanet":[
            "661"
        ],
        "gard":[
            "8535"
        ],
        "malacard":[
            "CNT119"
        ],
        "webstr_hg38":[
            "4725362"
        ],
        "webstr_hg19":[
            "Expansion_CCHS/PHOX2B"
        ],
        "tr_gnomad":[
            "TR42548"
        ],
        "disease_description":"A rare disease due to a severely impaired central autonomic control of breathing and dysfunction of the autonomous nervous system. The incidence is estimated to be at 1 of 200 000 livebirths. A heterozygous mutation of PHOX-2B gene is found in 90% of the patients. Association with a Hirschsprung's disease is observed in 16% of the cases (adapted from Mondo) [@mondo:0800026].",
        "locus_tags":["length_affects_onset", "length_affects_severity"],
        "disease_tags":[]
    },
    {
        "chrom":"chr15",
        "start_hg38":89333589,
        "stop_hg38":89333629,
        "start_hg19":89876820,
        "stop_hg19":89876860,
        "start_t2t":87088412,
        "stop_t2t":87088452,
        "id":"CPEO_POLG",
        "disease_id":"CPEO",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "GCT"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCT"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Progressive external ophthalmoplegia, Parkinson's disease",
        "gene":"POLG",
        "flank_motif":null,
        "locus_structure":"(CTG)*TTG(CTG)*",
        "inheritance":[],
        "type":"Coding",
        "location_in_gene":"Exon 2",
        "benign_min":10.0,
        "benign_max":10.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":null,
        "pathogenic_max":null,
        "ref_copies":13.7,
        "motif_len":3,
        "age_onset":"Typical: 57 [@pmid:20399836] - 59 [@pmid:20826197]; Range: 23-87 [@pmid:20399836].",
        "age_onset_min":23,
        "age_onset_max":87,
        "typ_age_onset_min":57.0,
        "typ_age_onset_max":59.0,
        "novel":"ref",
        "mechanism":null,
        "mechanism_detail":null,
        "source":[],
        "details":"There is conflicting evidence for the association between this repeat expansion and Parkinson's risk [@pmid:20399836; @pmid:10196696; @pmid:22963882], as well as overall disease significance. May be predisposing factor in earlier age of onset in FRDA patients [@pmid:19043662].",
        "omim":[
            "258450",
            "157640"
        ],
        "prevalence":null,
        "prevalence_details":"Disease association unclear but largely studied in European cohorts/patients [@omim:258450; @omim:157640].",
        "stripy":[],
        "gnomad":[],
        "genereviews":[],
        "mondo":[
            "0009783",
            "0024528"
        ],
        "year":null,
        "medgen":[
            "897191",
            "371919"
        ],
        "orphanet":[
            "520820"
        ],
        "gard":[
            "15215",
            "13174"
        ],
        "malacard":[
            "PRG130",
            "PRK002"
        ],
        "webstr_hg38":[
            "5177947"
        ],
        "webstr_hg19":[
            "STR_493430"
        ],
        "tr_gnomad":[
            "TR137533"
        ],
        "disease_description":"sensory ataxic neuropathy, dysarthria, and ophtalmoparesis [@pmid:38876750].",
        "locus_tags":["conflicting_evidence", "proposed_modifier"],
        "disease_tags":[]
    },
    {
        "chrom":"chr5",
        "start_hg38":146878728,
        "stop_hg38":146878759,
        "start_hg19":146258291,
        "stop_hg19":146258322,
        "start_t2t":147414734,
        "stop_t2t":147414765,
        "id":"SCA12_PPP2R2B",
        "disease_id":"SCA12",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "GCT"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCT"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinocerebellar ataxia type 12",
        "gene":"PPP2R2B",
        "flank_motif":null,
        "locus_structure":"(GCT)*",
        "inheritance":[
            "AD"
        ],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":6.0,
        "benign_max":32.0,
        "intermediate_min":40.0,
        "intermediate_max":49.0,
        "pathogenic_min":51.0,
        "pathogenic_max":78.0,
        "ref_copies":10.7,
        "motif_len":3,
        "age_onset":"Typical: 26-50; Range: 8-56 [@omim:604326].",
        "age_onset_min":8,
        "age_onset_max":62,
        "typ_age_onset_min":26.0,
        "typ_age_onset_max":50.0,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Polyalanine gain of function associated with RAN translation [@pmid:38467784].",
        "source":[],
        "details":"Benign range  is 6-32 repeats, intermediate range 40-49, and pathogenic range is 51-78 [@pmid:37906407]; intermediate alleles are associated with reduced penetrance [@pmid:11198281].",
        "omim":[
            "604326"
        ],
        "prevalence":null,
        "prevalence_details":"Frequent in India; rare in other populations [@pmid:34711523].",
        "stripy":[
            "PPP2R2B"
        ],
        "gnomad":[
            "PPP2R2B"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0011439"
        ],
        "year":"1999 [@pmid:10581021]",
        "medgen":[
            "347653"
        ],
        "orphanet":[
            "98762"
        ],
        "gard":[
            "10476"
        ],
        "malacard":[
            "SPN293"
        ],
        "webstr_hg38":[
            "985593",
            "6072892"
        ],
        "webstr_hg19":[
            "Expansion_SCA12/PPP2R2B"
        ],
        "tr_gnomad":[
            "TR59714"
        ],
        "disease_description":"Spinocerebellar ataxia type 12 (SCA12) is a very rare subtype of type I autosomal dominant cerebellar ataxia (ADCA type I). It is characterized by the presence of action tremor associated with relatively mild cerebellar ataxia. Associated pyramidal and extrapyramidal signs and dementia have been reported [@mondo:0011439].",
        "locus_tags":["length_affects_penetrance"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr9",
        "start_hg38":130681606,
        "stop_hg38":130681639,
        "start_hg19":133556993,
        "stop_hg19":133557026,
        "start_t2t":142886569,
        "stop_t2t":142886595,
        "id":"HSAN-VIII_PRDM12",
        "disease_id":"HSAN VIII",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCC"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CCG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Hereditary sensory and autonomic neuropathy type VIII",
        "gene":"PRDM12",
        "flank_motif":null,
        "locus_structure":"(GCC)*",
        "inheritance":[
            "AR"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 5",
        "benign_min":7.0,
        "benign_max":14.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":18.0,
        "pathogenic_max":19.0,
        "ref_copies":12.0,
        "motif_len":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Mutations abrogate the histone-modifying potential of PRDM12, consistent with a loss of function mechanism [@omim:616488].",
        "source":[],
        "details":"Pathogenic expansion found in 2 families, from whom pathogenic range (18-19) is inferred [@pmid:26005867]. Benign range (7-14) inferred from Human Gene Mutation Database [@genereviews:NBK535148].",
        "omim":[
            "616488"
        ],
        "prevalence":null,
        "prevalence_details":"Expansions found in 2 families from Pakistan and Saudi Arabia [@pmid:26005867]. All PRDM12 disease mutations < 1/1,000,000",
        "stripy":[
            "PRDM12"
        ],
        "gnomad":[
            "PRDM12"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0014662"
        ],
        "year":"2015 [@pmid:26005867]",
        "medgen":[
            "894363"
        ],
        "orphanet":[
            "478664"
        ],
        "gard":[
            "17866"
        ],
        "malacard":[
            "NRP044"
        ],
        "webstr_hg38":[
            "1543400"
        ],
        "webstr_hg19":[
            "STR_1521945"
        ],
        "tr_gnomad":[
            "TR97506"
        ],
        "disease_description":"A hereditary sensory neuropathy characterized by congenital insensitivity to pain and decreased sweating and tear production that has material basis in homozygous mutation in the PRDM12 gene on chromosome 9q34 [@mondo:0014662].",
        "locus_tags":["sparse_evidence"],
        "disease_tags":[]
    },
    {
        "chrom":"chr15",
        "start_hg38":88569434,
        "stop_hg38":88569449,
        "start_hg19":89112665,
        "stop_hg19":89112680,
        "start_t2t":86324039,
        "stop_t2t":86324054,
        "id":"pre-MIR7-2_CHNG3",
        "disease_id":"CHNG3",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "AAAC"
        ],
        "pathogenic_motif_reference_orientation":[
            "AAAC"
        ],
        "pathogenic_motif_gene_orientation":[
            "GTTT"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Nongoitrous congenital hypothyroidism-3",
        "gene":"pre-MIR7-2",
        "flank_motif":null,
        "locus_structure":"(TTTG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Non-coding",
        "location_in_gene":null,
        "benign_min":4.0,
        "benign_max":4.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":3.0,
        "pathogenic_max":3.0,
        "ref_copies":null,
        "motif_len":4,
        "age_onset":"0 (birth)",
        "age_onset_min":0.0,
        "age_onset_max":0.0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Activates a thyroid-specific enhancer [@pmid:38714868; @pmid:38714869].",
        "source":[],
        "details":"Deletion of one repeat (4 to 3 repeats) found in 10 unrelated families with unsolved disease [@pmid:38714869]; a heterozygous T-to-G transversion in the third repeat can also lead to disease [@pmid:38714868].",
        "omim":[
            "609893"
        ],
        "prevalence":null,
        "prevalence_details":"Found in 12 families, with ancestry including: Irish, White European, French (Normandie), Ashkenazi, French Canadian, Danish/White European, Welsh, Scottish, Italian, British/White European, Italian/Turkish/Lebanese, German/Palestinian, and South Chinese [@pmid:38714868].",
        "stripy":null,
        "gnomad":null,
        "genereviews":[],
        "mondo":[
            "0012360"
        ],
        "year":"2024 [@pmid:38714869]",
        "medgen":[
            "424853"
        ],
        "orphanet":[],
        "gard":[
            "1487"
        ],
        "malacard":["HYP355"],
        "webstr_hg38":[
            "5177365"
        ],
        "webstr_hg19":[
            "STR_492924"
        ],
        "tr_gnomad":[
            "TR192005"
        ],
        "disease_description":"Nongoitrous congenital hypothyroidism-3 (CHNG3) is characterized by infantile-onset clinical and subclinical hypothyroidism associated with a small thyroid gland, high circulating TSH, normal free T4 levels, and normal or mildly increased serum thyroglobulin. Untreated patients or patients who discontinue treatment show a characteristic transition to multinodular goiter (MNG) with age [@omim:609893].",
        "locus_tags":["contraction"],
        "disease_tags":[]
    },
    {
        "chrom":"chr20",
        "start_hg38":4699397,
        "stop_hg38":4699493,
        "start_hg19":4680043,
        "stop_hg19":4680139,
        "start_t2t":4738633,
        "stop_t2t":4738705,
        "id":"CJD_PRNP",
        "disease_id":"CJD",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GGTGGTGGCTGGGGGCAGCCTCAT"
        ],
        "pathogenic_motif_reference_orientation":[
            "CCTCATGGTGGTGGCTGGGGGCAG"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGCCTCATGGTGGTGGCTGGGGGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Creutzfeldt-Jakob disease",
        "gene":"PRNP",
        "flank_motif":"(CCTCAGGGCGGTGGTGGCTGGGGGCAG)1(CCTCATGGTGGTGGCTGGGGGCAG)n",
        "locus_structure":"(CCTCAGGGCGGTGGTGGCTGGGGGCAG)*(CCTCATGGTGGTGGCTGGGGGCAG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 2",
        "benign_min":4.0,
        "benign_max":4.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":5.0,
        "pathogenic_max":16.0,
        "ref_copies":null,
        "motif_len":24,
        "age_onset":"Typical: 50-60 [@genereviews:NBK1229]; Range: 31-63 [@pmid:37379724].",
        "age_onset_min":31,
        "age_onset_max":63,
        "typ_age_onset_min":50.0,
        "typ_age_onset_max":60.0,
        "novel":"ref",
        "mechanism":"LoF?",
        "mechanism_detail":"Loss of function hypothesized [@pmid:38467784]",
        "source":[],
        "details":"Normal PRNP alleles have one nonapeptide followed by four octapeptide tandem repeat sequences, each of which comprises the  amino acids: Pro-(His/Gln)-Gly-Gly-Gly-(-/Trp)-Gly-Gln; any additional repeat leads to pathogenicity, with the largest repeat observed 16 motifs [@genereviews:NBK1229]. Insertion length may correspond to phenotype, such as CJD versus frontotemporal dementia [@pmid:36977684].",
        "omim":[
            "123400"
        ],
        "prevalence":null,
        "prevalence_details":"<0.0225/1,000,000: <15% of CJ variants are repeat expansions [@genereviews:NBK535148]. 15% newly diagnosed prion disease cases are genetic [@genereviews:NBK1229], 1 individual per million per year worldwide (350 cases annually in US) [@pmid:29939637]. Found worldwide [@genereviews:NBK1229].",
        "stripy":[],
        "gnomad":[
            "PRNP"
        ],
        "genereviews":[
            "NBK1229"
        ],
        "mondo":[
            "0007403"
        ],
        "year":"1991 [@pmid:1683708]",
        "medgen":[
            "155837"
        ],
        "orphanet":[
            "282166"
        ],
        "gard":[
            "17307"
        ],
        "malacard":[
            "CRT072"
        ],
        "webstr_hg38":[],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR157963",
            "TR157964"
        ],
        "disease_description":"Inherited or familial Creutzfeldt-Jakob disease (fCJD) is a very rare form of genetic prion disease characterized by typical CJD features (rapidly progressive dementia, personality/behavioral changes, psychiatric disorders, myoclonus, and ataxia) with a genetic cause and sometimes a family history of dementia [@mondo:0007403].",
        "locus_tags":["length_affects_phenotype"],
        "disease_tags":[]
    },
    {
        "chrom":"chr17",
        "start_hg38":17808359,
        "stop_hg38":17808460,
        "start_hg19":17711673,
        "stop_hg19":17711774,
        "start_t2t":17754962,
        "stop_t2t":17755019,
        "id":"FAME8_RAI1",
        "disease_id":"FAME8",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "TTTTA"
        ],
        "pathogenic_motif_reference_orientation":[
            "TTTCA"
        ],
        "pathogenic_motif_gene_orientation":[
            "ATTTC"
        ],
        "benign_motif_reference_orientation":[
            "TTTTA"
        ],
        "benign_motif_gene_orientation":[
            "ATTTT"
        ],
        "unknown_motif_reference_orientation":[
            "GGGGT",
            "GGGAT"
        ],
        "unknown_motif_gene_orientation":[
            "GGGGT",
            "ATGGG"
        ],
        "disease":"Familial adult myoclonic epilepsy type 8",
        "gene":"RAI1",
        "flank_motif":null,
        "locus_structure":"(ATTTT)*(TTTCA)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 4",
        "benign_min":null,
        "benign_max":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":9.0,
        "pathogenic_max":334.0,
        "ref_copies":20.8,
        "motif_len":5,
        "age_onset":"7-68 (one family)",
        "age_onset_min":7,
        "age_onset_max":68,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"novel",
        "mechanism":"Unknown",
        "mechanism_detail":"Expression isn't changed [@pmid:7994247].",
        "source":[],
        "details":"TTTTA repeat expansions and TTTCA repeat insertions in intron 4 of the RAI1 gene that co-segregated with disease status in a single large family from Mali [@pmid:37994247]. Ten affected individuals were studied. Both TTTTA and TTTCA motifs were observed in all eight of the affected individuals with spanning reads, with allele sizes in the range: (TTTTA)278-773(TTTCA)9-334. A single individual was observed with additional motifs and interruptions in one allele with the structure: (TTTTA)exp(GGGGT)ins(GGGAT)ins(TTTCA)ins. TTTCA repeats were absent in 200 Malian controls, who had alleles in the range: (TTTCA)16-20. Reviewed in [@pmid:38876750]. It is uncertain if expansions at both the TTTTA and TTTCA motifs, or only the TTTCA motif are required for pathogogenicity. The pathogenic range in STRchive is for the TTTCA motif only. Note: locus is partially deleted in T2T reference genome",
        "omim":[],
        "prevalence":null,
        "prevalence_details":"Observed in a single family from Mali with ten affected individuals [@pmid:37994247].",
        "stripy":[],
        "gnomad":[],
        "genereviews":[],
        "mondo":[],
        "year":"2024 [@pmid:PMID:37994247]",
        "medgen":[],
        "orphanet":[
            "86814"
        ],
        "gard":[
            "16758"
        ],
        "malacard":[],
        "webstr_hg38":[
            "486849"
        ],
        "webstr_hg19":[],
        "tr_gnomad":[],
        "disease_description":"Cortical tremor, seizures with generalised motor (tonic-clonic) onset [@pmid:38876750].",
        "locus_tags":["motif_affects_onset"],
        "disease_tags":["Familial adult myoclonic epilepsy"]
    },
    {
        "chrom":"chr4",
        "start_hg38":159342527,
        "stop_hg38":159342618,
        "start_hg19":160263679,
        "stop_hg19":160263770,
        "start_t2t":162693304,
        "stop_t2t":162693405,
        "id":"FAME7_RAPGEF2",
        "disease_id":"FAME7",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "TTTTA"
        ],
        "pathogenic_motif_reference_orientation":[
            "TTTCA"
        ],
        "pathogenic_motif_gene_orientation":[
            "ATTTC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[
            "TTTTT",
            "TTATG"
        ],
        "unknown_motif_gene_orientation":[
            "TTTTT",
            "ATGTT"
        ],
        "disease":"Familial adult myoclonic epilepsy type 7",
        "gene":"RAPGEF2",
        "flank_motif":null,
        "locus_structure":"(TTTTA)*(TTTCA)*(TTTTA)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 14",
        "benign_min":null,
        "benign_max":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":60.0,
        "pathogenic_max":2200.0,
        "ref_copies":17.4,
        "motif_len":5,
        "age_onset":"Typical: 20-33 [@pmid:30351492]; Range: 18 [@pmid:29507423] - 37 [@pmid:30351492].",
        "age_onset_min":18,
        "age_onset_max":37,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"novel",
        "mechanism":"GoF?",
        "mechanism_detail":"RNA toxicity hypothesized [@pmid:29507423].",
        "source":[],
        "details":"The locus structure is (TTTTA)exp(TTTCA)exp(TTTTA)n, where only the TTTCA is specific to affected individuals as a pathogenic insertion [@pmid:29507423; @pmid:30351492]. Pathogenic expansions range from 60 to thousands of repeats [@pmid:29507423; @pmid:30351492]. Interruptions seen: TATTA, TTTTTA [@pmid:35245110].",
        "omim":[
            "618075"
        ],
        "prevalence":null,
        "prevalence_details":"FAME overall is 1/35,000 in Japan. Repeat expansion found in individuals of East Asian ancestry [@pmid:38876750].",
        "stripy":[
            "RAPGEF2"
        ],
        "gnomad":[
            "RAPGEF2"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0054847"
        ],
        "year":"2018 [@pmid:29507423]",
        "medgen":[
            "1648435"
        ],
        "orphanet":[
            "86814"
        ],
        "gard":[
            "16758"
        ],
        "malacard":[
            "EPL228"
        ],
        "webstr_hg38":[
            "154264",
            "4792219"
        ],
        "webstr_hg19":[
            "STR_1096016"
        ],
        "tr_gnomad":[
            "TR49300"
        ],
        "disease_description":"Cortical tremor, seizures with generalised motor (tonic-clonic) onset [@pmid:38876750].",
        "locus_tags":["motif_affects_penetrance"],
        "disease_tags":["Familial adult myoclonic epilepsy"]
    },
    {
        "chrom":"chr4",
        "start_hg38":39348425,
        "stop_hg38":39348483,
        "start_hg19":39350045,
        "stop_hg19":39350103,
        "start_t2t":39318078,
        "stop_t2t":39318136,
        "id":"CANVAS_RFC1",
        "disease_id":"CANVAS",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "AAAAG"
        ],
        "pathogenic_motif_reference_orientation":[
            "AAGGG",
            "ACAGG",
            "AGGGC",
            "AAGGC",
            "AGAGG"
        ],
        "pathogenic_motif_gene_orientation":[
            "CCCTT",
            "CCTGT",
            "CCCTG",
            "CCTTG",
            "CCTCT"
        ],
        "benign_motif_reference_orientation":[
            "AAAAG",
            "AAAGG",
            "AAGAG",
            "AAAGGG"

        ],
        "benign_motif_gene_orientation":[
            "CTTTT",
            "CCTTT",
            "CTCTT",
            "CCCTTT"
        ],
        "unknown_motif_reference_orientation":[
            "AAAAA",
            "AAAAC",
            "AACGG",
            "AAGAC",
            "AAGGT",
            "AGAAC",
            "AGGGG",
            "GAAAC",
            "GGGAC",
            "GTGAG",
            "AAAAGA",
            "AAAGGA",
            "GGAAAG"
        ],
        "unknown_motif_gene_orientation":[
            "TTTTT",
            "GTTTT",
            "CCGTT",
            "CTTGT",
            "ACCTT",
            "CTGTT",
            "CCCCT",
            "CGTTT",
            "CCCGT",
            "ACCTC",
            "CTTTTT",
            "CCTTTT",
            "CCCTTT"
        ],
        "disease":"Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome",
        "gene":"RFC1",
        "flank_motif":null,
        "locus_structure":"(AAGGG)*(ACAGG)*",
        "inheritance":[
            "AR"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 2",
        "benign_min":0.0,
        "benign_max":11.0,
        "intermediate_min":11.0,
        "intermediate_max":200.0,
        "pathogenic_min":400.0,
        "pathogenic_max":2750.0,
        "ref_copies":11.8,
        "motif_len":5,
        "age_onset":"Typical: 36-52; Range: 19-76 [@genereviews:NBK564656].",
        "age_onset_min":19,
        "age_onset_max":76,
        "typ_age_onset_min":36.0,
        "typ_age_onset_max":52.0,
        "novel":"novel",
        "mechanism":"LoF",
        "mechanism_detail":"LoF; exact mechanism unknown [@pmid:38467784].",
        "source":[],
        "details":"Disease is caused by an insertion of a pathogenic motif, although motif presence is variable and can expand up to 200 repeats without apparently causing a phenotype [@genereviews:NBK564656]. Pathogenic expansions (ranging from 400-2750 pathogenic motifs) may be flanked by other motifs [@genereviews:NBK564656]. For example, (AAAGG)10-25(AAGGG)exp(AAAGG)4-6 [@pmid:32851396]. Motif heterogeneity is common in unaffected individuals [@genereviews:NBK564656], and motif associations are described by Delforge et al [pmid:38627134]. The pathogenic size threshold appears to differ for the AAAGG motif: AAAGG expansions >= 600 repeats have been observed in CANVAS patients (vs 400 with established pathogenic motif AAGGG), while ~100-380 AAAGG repeats were found in unaffected controls [@pmid:37450567]. Length appears to impact age of onset and disease severity, with particular impact from the smaller allele [@doi:10.1136/jnnp-2024-ABN.259].",
        "omim":[
            "614575"
        ],
        "prevalence":null,
        "prevalence_details":"Carrier frequency in European is 0.7-4% and in Chinese Han population is 2.24%; estimated prevalence of 1/20,000 to 1/625 [@genereviews:NBK564656]. Many cases are likely not diagnosed due to heterogeneous presentation [@pmid:39230846]. Observed in multiple ethnicities [@pmid:38876750]; patients diagnosed with European, Chinese Han, and Maori ancestry, as well as found in Japan, Canada, Brazil, the UK, Italy, Germany, and Australia [@genereviews:NBK564656].",
        "stripy":[
            "RFC1"
        ],
        "gnomad":[
            "RFC1"
        ],
        "genereviews":[
            "NBK564656"
        ],
        "mondo":[
            "0044720"
        ],
        "year":"2019 [@pmid:31230722]",
        "medgen":[
            "482853"
        ],
        "orphanet":[
            "504476"
        ],
        "gard":[
            "17937"
        ],
        "malacard":[
            "CRB196"
        ],
        "webstr_hg38":[
            "4722884",
            "99101"
        ],
        "webstr_hg19":[
            "STR_1036603"
        ],
        "tr_gnomad":[
            "TR42349"
        ],
        "disease_description":"Sensory disturbances, imbalance, oscillopsia, chronic dry cough, dysarthria and dysphagia [@pmid:38876750]; Late-onset ataxia, sensory neuropathy, vestibular areflexia syndrome [@pmid:39349043].",
        "locus_tags":["motif_affects_penetrance", "length_affects_onset", "length_affects_severity"],
        "disease_tags":[
            "ataxia"
        ]
    },
    {
        "chrom":"chr12",
        "start_hg38":123533720,
        "stop_hg38":123533755,
        "start_hg19":124018267,
        "stop_hg19":124018302,
        "start_t2t":123532574,
        "stop_t2t":123532608,
        "id":"OPDM4_RILPL1",
        "disease_id":"OPDM4",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "GGC"
        ],
        "pathogenic_motif_reference_orientation":[
            "GGC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CCG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Oculopharyngodistal myopathy type 4",
        "gene":"RILPL1",
        "flank_motif":null,
        "locus_structure":"(GGC)*",
        "inheritance":[
            "AD"
        ],
        "type":"5' UTR",
        "location_in_gene":null,
        "benign_min":6.0,
        "benign_max":16.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":120.0,
        "pathogenic_max":197.0,
        "ref_copies":11.7,
        "motif_len":3,
        "age_onset":"Typical: 18-30 [@pmid:35148830]; Range: 10-30 [@pmid:35700120].",
        "age_onset_min":10,
        "age_onset_max":30,
        "typ_age_onset_min":18.0,
        "typ_age_onset_max":30.0,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Polyglutamine expansion leading to RNA-mediated gain-of-function mechanism [@pmid:38467784].",
        "source":[],
        "details":"Benign alleles have been documented to have 6-16 repeats [@pmid:37864208], while pathogenic repeats range from 120 to 197 repeats; there is no apparent relationship between allele size and age of onset [@pmid:37864208; @pmid:35148830]. Intermediate alleles amy be associated with incomplete penetrance, or milder phenotypes [@pmid:35148830]. AGG and TGG interruptions observed [@pmid:35148830].",
        "omim":[],
        "prevalence":null,
        "prevalence_details":"Population dependent: 21.6% of one OPDM cohort [@pmid:35148830]. Typically found in individuals of East Asian ancestry [@pmid:38876750].",
        "stripy":[
            "RILPL1"
        ],
        "gnomad":[],
        "genereviews":[],
        "mondo":[
            "0030712"
        ],
        "year":"2022 [@pmid:35148830]",
        "medgen":[
            "1809981"
        ],
        "orphanet":[
            "98897"
        ],
        "gard":[
            "12592"
        ],
        "malacard":[
            "OCL085"
        ],
        "webstr_hg38":[
            "5128610",
            "609239"
        ],
        "webstr_hg19":[
            "STR_347096"
        ],
        "tr_gnomad":[
            "TR121403"
        ],
        "disease_description":"Ptosis, external ophthalmoplegia, facial weakness, and pharyngeal and distal limb weakness [@pmid:38876750].",
        "locus_tags":[],
        "disease_tags":["Oculopharyngodistal myopathy"]
    },
    {
        "chrom":"chr6",
        "start_hg38":45422750,
        "stop_hg38":45422792,
        "start_hg19":45390487,
        "stop_hg19":45390529,
        "start_t2t":45257567,
        "stop_t2t":45257611,
        "id":"CCD_RUNX2",
        "disease_id":"CCD",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Cleidocranial dysplasia",
        "gene":"RUNX2",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 3",
        "benign_min":4.0,
        "benign_max":17.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":20.0,
        "pathogenic_max":27.0,
        "ref_copies":15.0,
        "motif_len":3,
        "age_onset":"0 (birth) [@genereviews:NBK1513].",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Polyalanine expansion leading to haploinsufficiency [@pmid:26220009].",
        "source":[],
        "details":"Benign range (4-17 repeats) established from gnomAD and primary literature; pathogenic ranges (20-27) reflect two clinical cases to date [@gnomad:RUNX2; @pmid:26220009]. Intermediate alleles (i.e, 18 repeats; 19 not reported) appear to not be associated with disease [@pmid:20560987; @pmid:26220009].",
        "omim":[
            "119600"
        ],
        "prevalence":null,
        "prevalence_details":"All conditions 1/1,000,000 births (likely underdiagnosed); Utah population frequency 0.12/10,000. Found in many ethnic groups [@orphanet:1452]. TR expansions causative in 2 individuals [@genereviews:NBK535148].",
        "stripy":[
            "RUNX2"
        ],
        "gnomad":[
            "RUNX2"
        ],
        "genereviews":[
            "NBK1513"
        ],
        "mondo":[
            "0007340"
        ],
        "year":"Causation identified in 2015 [@pmid:26220009]; clinical association found in 1997 [@pmid:9182765]",
        "medgen":[
            "3486"
        ],
        "orphanet":[
            "1452"
        ],
        "gard":[
            "6118"
        ],
        "malacard":[
            "CLD001"
        ],
        "webstr_hg38":[
            "5789216"
        ],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR65117"
        ],
        "disease_description":"A condition that primarily affects the development of the bones and teeth. Characteristic features include underdeveloped or absent collarbones (clavicles); dental abnormalities; and delayed closing of the spaces between the skull bones (fontanels). Other features may include decreased bone density (osteopenia), osteoporosis, hearing loss, bone abnormalities of the hands, and recurrent sinus and ear infections. [@mondo:0007340].",
        "locus_tags":[],
        "disease_tags":[]
    },
    {
        "chrom":"chr8",
        "start_hg38":118366813,
        "stop_hg38":118366918,
        "start_hg19":119379052,
        "stop_hg19":119379157,
        "start_t2t":119495248,
        "stop_t2t":119495353,
        "id":"FAME1_SAMD12",
        "disease_id":"FAME1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "TAAAA"
        ],
        "pathogenic_motif_reference_orientation":[
            "TGAAA"
        ],
        "pathogenic_motif_gene_orientation":[
            "ATTTC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[
            "AAAAA",
            "TAAAC",
            "TAACA",
            "TACAA",
            "TACAC"
        ],
        "unknown_motif_gene_orientation":[
            "TTTTT",
            "AGTTT",
            "ATGTT",
            "ATTGT",
            "AGTGT"
        ],
        "disease":"Familial adult myoclonic epilepsy type 1",
        "gene":"SAMD12",
        "flank_motif":null,
        "locus_structure":"(TAAAA)*(TGAAA)*(TAAAA)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 4/4",
        "benign_min":null,
        "benign_max":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":105.0,
        "pathogenic_max":3680.0,
        "ref_copies":21.6,
        "motif_len":5,
        "age_onset":"Typical: 21-39 [@pmid:29939203]; Range: 12 [@pmid:29939203] - 68 [@pmid:29507423].",
        "age_onset_min":12,
        "age_onset_max":68,
        "typ_age_onset_min":21.0,
        "typ_age_onset_max":39.0,
        "novel":"novel",
        "mechanism":"GoF?",
        "mechanism_detail":"RNA mediated gain of function proposed [@omim:601068; @pmid: 38467784].",
        "source":[],
        "details":"Novel, pathogenic alleles include expansions of TTTTAn + TTTCAn, but only the TTTCA insertion is specific to affected individuals; pathogenic expansions range from 105 to 3860 repeats [@omim:601068; @pmid:29507423]",
        "omim":[
            "601068"
        ],
        "prevalence":null,
        "prevalence_details":"FAME overall is 1/35,000 in Japan. Typically found in individuals of East Asian ancestry [@pmid:38876750].",
        "stripy":[
            "SAMD12"
        ],
        "gnomad":[
            "SAMD12"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0010985"
        ],
        "year":"2018 [@pmid:29507423]",
        "medgen":[
            "371424"
        ],
        "orphanet":[
            "86814"
        ],
        "gard":[
            "18082"
        ],
        "malacard":[
            "EPL201"
        ],
        "webstr_hg38":[
            "1087693"
        ],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR89226"
        ],
        "disease_description":"Cortical tremor, seizures with generalised motor (tonic-clonic) onset [@pmid:38876750]; Adult-onset cortical myoclonus, with seizures in up to a half of patients [@pmid:39349043].",
        "locus_tags":["somatic_instability", "anticipation", "motif_affects_instability", "motif_affects_onset", "motif_affects_penetrance"],
        "disease_tags":["Familial adult myoclonic epilepsy"]
    },
    {
        "chrom":"chrX",
        "start_hg38":140504316,
        "stop_hg38":140504361,
        "start_hg19":139586481,
        "stop_hg19":139586526,
        "start_t2t":138816205,
        "stop_t2t":138816239,
        "id":"XLMR_SOX3",
        "disease_id":"XLMR",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_reference_orientation":[
            "NGC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"X-linked panhypopituitarism ; X-linked mental retardation with isolated growth hormone",
        "gene":"SOX3",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "inheritance":[
            "XR"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "benign_min":15.0,
        "benign_max":15.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":22.0,
        "pathogenic_max":26.0,
        "ref_copies":15.0,
        "motif_len":3,
        "age_onset":"Typical: 0-3 (small sample size) [@pmid:19654509; @pmid:21289259]; range: 0-9 [@pmid:19654509].",
        "age_onset_min":0,
        "age_onset_max":9,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Polyalanine expansions leading to aggresome formation and impaired transcriptional activity [@pmid:17127446].",
        "source":[],
        "details":"Expansion to 22-26 repeats or contraction to 8 repeats can cause disease, as reported in 3 families [@genereviews:NBK535148].",
        "omim":[
            "300123",
            "312000"
        ],
        "prevalence":null,
        "prevalence_details":"3 families reported, however they were distributed across the world [@omim:300123].",
        "stripy":[
            "SOX3"
        ],
        "gnomad":[
            "SOX3"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0010252"
        ],
        "year":"2002 [@pmid:12428212]",
        "medgen":[
            "394771"
        ],
        "orphanet":[
            "67045"
        ],
        "gard":[],
        "malacard":[
            "PNH005",
            "INT405"
        ],
        "webstr_hg38":[],
        "webstr_hg19":[
            "STR_1597784"
        ],
        "tr_gnomad":[
            "TR173479"
        ],
        "disease_description":"X-linked isolated growth hormone deficiency (GHD) or combined pituitary hormone deficiency (CPHD) patients with or without [intellectual disability] [@pmid:24346842].",
        "locus_tags":["sparse_evidence", "contraction"],
        "disease_tags":[]
    },
    {
        "chrom":"chr2",
        "start_hg38":96197067,
        "stop_hg38":96197121,
        "start_hg19":96862805,
        "stop_hg19":96862859,
        "start_t2t":96703675,
        "stop_t2t":96703729,
        "id":"FAME2_STARD7",
        "disease_id":"FAME2",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "AAAAT"
        ],
        "pathogenic_motif_reference_orientation":[
            "AAATG"
        ],
        "pathogenic_motif_gene_orientation":[
            "ATTTC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[
            "AAAAA",
            "AAAAC",
            "AAACC",
            "AAACG",
            "AAACT",
            "AACTC",
            "AACTG",
            "AATAC",
            "AATAG",
            "ATAAC"
        ],
        "unknown_motif_gene_orientation":[
            "TTTTT",
            "GTTTT",
            "GGTTT",
            "CGTTT",
            "AGTTT",
            "AGTTG",
            "AGTTC",
            "ATTGT",
            "ATTCT",
            "ATGTT"
        ],
        "disease":"Familial adult myoclonic epilepsy 2",
        "gene":"STARD7",
        "flank_motif":null,
        "locus_structure":"(AAATG)*(AAAAT)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "benign_min":null,
        "benign_max":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":274.0,
        "pathogenic_max":558.0,
        "ref_copies":11.6,
        "motif_len":5,
        "age_onset":"Typical: 12-30; Range: 4-60 [@pmid:31664034].",
        "age_onset_min":4,
        "age_onset_max":60,
        "typ_age_onset_min":12.0,
        "typ_age_onset_max":30.0,
        "novel":"novel",
        "mechanism":"GoF?",
        "mechanism_detail":"RNA toxicity theorized [@pmid:31664034; @pmid:38467784].",
        "source":[],
        "details":"Disease caused by novel insertion of pathogenic motif (not found in any controls); size of pathogenic motif observed in two probands ranged from ~274-558 repeats, while the expanded reference motif ranged from 340-390 [@pmid:31664034].",
        "omim":[
            "607876"
        ],
        "prevalence":null,
        "prevalence_details":"This repeat expansion is typically found in individuals of European ancestry [@pmid:38876750].",
        "stripy":[
            "STARD7"
        ],
        "gnomad":[
            "STARD7"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0011930"
        ],
        "year":"2019 [@pmid:31664034]",
        "medgen":[
            "375031"
        ],
        "orphanet":[
            "86814"
        ],
        "gard":[
            "18083"
        ],
        "malacard":[
            "EPL203"
        ],
        "webstr_hg38":[
            "286156"
        ],
        "webstr_hg19":[
            "STR_754470"
        ],
        "tr_gnomad":[
            "TR19329"
        ],
        "disease_description":"Finger, hand tremor with later-onset myoclonus and generalised tonic-clonic seizures [@pmid:39349043].",
        "locus_tags":["somatic_instability", "motif_affects_instability", "motif_affects_penetrance"],
        "disease_tags":["Familial adult myoclonic epilepsy"]
    },
    {
        "chrom":"chrX",
        "start_hg38":71453055,
        "stop_hg38":71453129,
        "start_hg19":70672905,
        "stop_hg19":70672979,
        "start_t2t":69887154,
        "stop_t2t":69887228,
        "id":"XDP_TAF1",
        "disease_id":"XDP",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "AGAGGG"
        ],
        "pathogenic_motif_reference_orientation":[
            "AGAGGG"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGAGGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"X-linked dystonia-parkinsonism (XDP) a.k.a. Dystonia 3, torsion, X-linked (DYT3)",
        "gene":"TAF1",
        "flank_motif":null,
        "locus_structure":"(AGAGGG)*",
        "inheritance":[
            "XR"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 32",
        "benign_min":null,
        "benign_max":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":35.0,
        "pathogenic_max":52.0,
        "ref_copies":4.0,
        "motif_len":6,
        "age_onset":"Average age of onset for XDP is 39.7 years in males, 52 years in females, range 12-79 years. ~99% of cases are male [@pmid:29229810; @pmid:38876750; @pmid:15596620].",
        "age_onset_min":12,
        "age_onset_max":79,
        "typ_age_onset_min":39.7,
        "typ_age_onset_max":39.7,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Altered splicing with intron retention, haploinsufficiency [@pmid:38876750].",
        "source":[],
        "details":"Strong inverse relationship between age of onset and insertion length, which varied between 35-52 repeats [@pmid:29229810].",
        "omim":[
            "314250"
        ],
        "prevalence":null,
        "prevalence_details":"Philippines overall 0.34:100,000. Panay Islands 5.24:100,000. Capiz province 18.9:100,000. To date, all known cases to date are of Filipino descent [@pmid:38876750].",
        "stripy":[],
        "gnomad":[],
        "genereviews":[
            "NBK1489"
        ],
        "mondo":[
            "0010747"
        ],
        "year":"2017 [@pmid:29229810]",
        "medgen":[
            "326820"
        ],
        "orphanet":[
            "53351"
        ],
        "gard":[
            "10533"
        ],
        "malacard":[
            "DYS064"
        ],
        "webstr_hg38":[
            "861907"
        ],
        "webstr_hg19":[
            "STR_1564408"
        ],
        "tr_gnomad":[
            "TR592600"
        ],
        "disease_description":"X-linked dystonia-parkinsonism (XDP) associated with antisense insertion of a SINE-VNTR-Alu (SVA)-type retrotransposon within an intron of TAF1. Clinical features include focal and generalised dystonia, parkinsonism, cognitive dysfunction. XX individuals who are heterozygous carriers usually do not develop the full syndrome, although some patients have non-progressive focal dystonia with parkinsonism. Disease severity is associated with number of hexanucleotide repeats within the SVA. (Adapted) [@pmid:38876750].",
        "locus_tags":["length_affects_onset"],
        "disease_tags":[]
    },
    {
        "chrom":"chr6",
        "start_hg38":170561907,
        "stop_hg38":170562017,
        "start_hg19":170870995,
        "stop_hg19":170871105,
        "start_t2t":171935459,
        "stop_t2t":171935569,
        "id":"SCA17_TBP",
        "disease_id":"SCA17",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCA"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCA"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinocerebellar ataxia type 17",
        "gene":"TBP",
        "flank_motif":null,
        "locus_structure":"(GCA)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 3",
        "benign_min":25.0,
        "benign_max":40.0,
        "intermediate_min":41.0,
        "intermediate_max":48.0,
        "pathogenic_min":49.0,
        "pathogenic_max":66.0,
        "ref_copies":37.0,
        "motif_len":3,
        "age_onset":"Typical: 19-48; Range: 3-62, has second variant to delay onset [@omim:607136].",
        "age_onset_min":3,
        "age_onset_max":62,
        "typ_age_onset_min":19.0,
        "typ_age_onset_max":48.0,
        "novel":"ref",
        "mechanism":"LoF/GoF",
        "mechanism_detail":"Polyglutamine expansion leading to transcriptional dysregulation [@pmid:35053321].",
        "source":[],
        "details":"Benign range is 25-40 repeats, pathogenic range is 49+ repeats (largest to date 66 motifs, with mild correlation between size and age of onset), and intermediate alleles (41-48 repeats) are associated with reduced penetrance and potentially milder phenotypes [@genereviews:NBK1438]. Huntington's disease like phenotype [@pmid:12805114]. Interruptions seen: CAA [@pmid:35245110]; CAA CAG CAA interruption is seen in all alleles stably transmitted across generations [@genereviews:NBK1438].",
        "omim":[
            "607136"
        ],
        "prevalence":"0.2/100000",
        "prevalence_details":"Unknown (global), <100 families, 0.47:1,000,000 (Japanese), 0.16/100,000 (England) [@genereviews:NBK1438; @pmid:29100084]: 0.2/100,000. Found across ethnicities/ancestries, with population-dependent prevalence [@genereviews:NBK1438].",
        "stripy":[
            "TBP"
        ],
        "gnomad":[
            "TBP"
        ],
        "genereviews":[
            "NBK1438"
        ],
        "mondo":[
            "0011781"
        ],
        "year":"1999 [@pmid:10484774]",
        "medgen":[
            "337637"
        ],
        "orphanet":[
            "98759"
        ],
        "gard":[
            "10469"
        ],
        "malacard":[
            "SPN296"
        ],
        "webstr_hg38":[
            "83566"
        ],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR72502"
        ],
        "disease_description":"A rare subtype of type I autosomal dominant cerebellar ataxia (ADCA type I). It is characterized by a variable clinical picture which can include dementia, psychiatric disorders, parkinsonism, dystonia, chorea, spasticity, and epilepsy [@mondo:0011781].",
        "locus_tags":["somatic_instability", "anticipation", "paternal_expansion", "length_affects_onset", "length_affects_penetrance", "length_affects_phenotype", "motif_affects_instability"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr22",
        "start_hg38":19766762,
        "stop_hg38":19766807,
        "start_hg19":19754285,
        "stop_hg19":19754330,
        "start_t2t":20143615,
        "stop_t2t":20143660,
        "id":"TOF_TBX1",
        "disease_id":"TOF",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Tetralogy of Fallot",
        "gene":"TBX1",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 9",
        "benign_min":15.0,
        "benign_max":15.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":25.0,
        "pathogenic_max":25.0,
        "ref_copies":15.0,
        "motif_len":3,
        "age_onset":"0",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF/GoF",
        "mechanism_detail":"Polyalanine expansion, leading to cytoplasmic aggregation [@omim:187500; @pmid:19948535].",
        "source":[],
        "details":"Found in one Turkish individual with Tetralogy of Fallot who had 25 repeats rather than 15 [@genereviews:NBK535148].",
        "omim":[
            "187500"
        ],
        "prevalence":null,
        "prevalence_details":"Found in one Turkish individual [@genereviews:NBK535148].",
        "stripy":[
            "TBX1"
        ],
        "gnomad":[
            "TBX1"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0008542"
        ],
        "year":"2010 [@pmid:19948535]",
        "medgen":[
            "21498"
        ],
        "orphanet":[
            "3303"
        ],
        "gard":[
            "2245"
        ],
        "malacard":[
            "TTR001"
        ],
        "webstr_hg38":[
            "4900984"
        ],
        "webstr_hg19":[
            "STR_889797"
        ],
        "tr_gnomad":[
            "TR163862"
        ],
        "disease_description":"Tetralogy of Fallot is a congenital cardiac malformation that consists of an interventricular communication, also known as a ventricular septal defect, obstruction of the right ventricular outflow tract, override of the ventricular septum by the aortic root, and right ventricular hypertrophy [@mondo:0008542].",
        "locus_tags":["sparse_evidence"],
        "disease_tags":[]
    },
    {
        "chrom":"chr18",
        "start_hg38":55586155,
        "stop_hg38":55586227,
        "start_hg19":53253386,
        "stop_hg19":53253458,
        "start_t2t":55789234,
        "stop_t2t":55789288,
        "id":"FECD3_TCF4",
        "disease_id":"FECD3",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "CAG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CAG"
        ],
        "pathogenic_motif_gene_orientation":[
            "CTG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Fuchs endothelial corneal dystrophy 3",
        "gene":"TCF4",
        "flank_motif":null,
        "locus_structure":"(CAG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "benign_min":10.0,
        "benign_max":39.0,
        "intermediate_min":40.0,
        "intermediate_max":50.0,
        "pathogenic_min":51.0,
        "pathogenic_max":2600.0,
        "ref_copies":25.3,
        "motif_len":3,
        "age_onset":"Typical: 40-59 [@pmid:1676829]; Range: 32 [@pmid:21245398] - 70 [@pmid:25168903].",
        "age_onset_min":32,
        "age_onset_max":70,
        "typ_age_onset_min":40.0,
        "typ_age_onset_max":59.0,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Sequestration of MBNL1 in RNA foci, similar to the mechanism underlying myotonic dystrophy-1 [@pmid:25593321]. Variation in RAN translation [@pmid:38467784].",
        "source":[],
        "details":"Most controls have <40 repeats while majority of patients have >50 repeats; penetrance is <100%, as unaffected individuals have been documented with >80 repeats and alleles of affected individuals range from 12-2600 [@genereviews:NBK535148; @pmid:25168903]. Expansions are causative in approximately 70% of disease cases [@genereviews:NBK535148].",
        "omim":[
            "613267"
        ],
        "prevalence":"4.5/100",
        "prevalence_details":"~4/100 (over 40) [@omim:613267]; 5/100 [@pmid:20825314]. Predominantly in women (~75%) [@pmid:16769829]. Although studies on the prevalence of FECD worldwide are limited, the disorder is thought to be more common in Eurasian populations [@pmid:26401622], with its corneal manifestations documented in 11% of females and 7% of males in Reykjavik, Iceland, 8.5 % of Singapore Chinese, and 5.5% of Japanese [@pmid:25722209]. Uncommon/rare in Saudi Arabia, Singaporean Chinese, and Japan [@orphanet:98974].",
        "stripy":[
            "TCF4"
        ],
        "gnomad":[
            "TCF4"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0013203"
        ],
        "year":"2012 [@pmid:23185296]",
        "medgen":[
            "442479"
        ],
        "orphanet":[
            "98974"
        ],
        "gard":[
            "10018"
        ],
        "malacard":[
            "FCH001",
            "CRN120"
        ],
        "webstr_hg38":[
            "6247607",
            "463325"
        ],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR151784"
        ],
        "disease_description":"Late-onset Fuchs endothelial corneal dystrophy (FECD) is a degenerative disorder ... distinguished from other corneal disorders by the progressive formation of guttae [@omim:613267].",
        "locus_tags":["length_affects_penetrance"],
        "disease_tags":[]
    },
    {
        "chrom":"chr16",
        "start_hg38":67842863,
        "stop_hg38":67842950,
        "start_hg19":67876766,
        "stop_hg19":67876853,
        "start_t2t":73638637,
        "stop_t2t":73638724,
        "id":"SCA_THAP11",
        "disease_id":"SCA",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "CAG"
        ],
        "pathogenic_motif_reference_orientation":[
            "CAG"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinocerebellar ataxia",
        "gene":"THAP11",
        "flank_motif":null,
        "locus_structure":"(CAG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "benign_min":20.0,
        "benign_max":38.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":45.0,
        "pathogenic_max":100.0,
        "ref_copies":29.3,
        "motif_len":3,
        "age_onset":"Typical: 8-40 (small sample size); Range: 4-51 [@pmid:37148549].",
        "age_onset_min":4,
        "age_onset_max":51,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"GoF",
        "mechanism_detail":"Polyglutamine expansion leading to gain of function toxicity [@pmid:37148549; @pmid:38467784].",
        "source":[],
        "details":"Expansion (45-100 repeats) found in affected individuals from 2 families and not in 500 controls (benign range: 20-38 repeats) [@pmid:37148549]. Longer alleles were associated with earlier age of onset. For example, an individual with 100 repeats had age of onset at 4 years. CAA interruptions can reduce toxicity [@pmid:37148549].",
        "omim":[],
        "prevalence":null,
        "prevalence_details":"Has been observed in Chinese families [@pmid:37148549; @pmid:24677642].",
        "stripy":[],
        "gnomad":[],
        "genereviews":[],
        "mondo":[],
        "year":"2023 [@pmid:37148549]",
        "medgen":[
            "431598"
        ],
        "orphanet":[],
        "gard":[
            "10748"
        ],
        "malacard":[],
        "webstr_hg38":[
            "814002",
            "5973136"
        ],
        "webstr_hg19":[
            "STR_540982"
        ],
        "tr_gnomad":[
            "TR142069"
        ],
        "disease_description":"THAP11-caused SCA involves symptoms including gait ataxia, dysarthia, dysphagia, slow saccades, ptosis, and/or nystagmus [@pmid:37148549].",
        "locus_tags":["anticipation", "length_affects_onset", "length_affects_severity", "motif_affects_onset", "motif_affects_severity"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr16",
        "start_hg38":24613439,
        "stop_hg38":24613532,
        "start_hg19":24624760,
        "stop_hg19":24624853,
        "start_t2t":24890367,
        "stop_t2t":24890430,
        "id":"FAME6_TNRC6A",
        "disease_id":"FAME6",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "TTTTA"
        ],
        "pathogenic_motif_reference_orientation":[
            "TTTCA"
        ],
        "pathogenic_motif_gene_orientation":[
            "ATTTC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[
            "TTTTT"
        ],
        "unknown_motif_gene_orientation":[
            "TTTTT"
        ],
        "disease":"Familial adult myoclonic epilepsy type 6",
        "gene":"TNRC6A",
        "flank_motif":null,
        "locus_structure":"(TTTTA)*(TTTCA)*(TTTTA)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Exon 1",
        "benign_min":null,
        "benign_max":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":1100.0,
        "pathogenic_max":1100.0,
        "ref_copies":18.8,
        "motif_len":3,
        "age_onset":"Limited clinical details from one family, 'early 20s to 70s'",
        "age_onset_min":23,
        "age_onset_max":74,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"novel",
        "mechanism":"GoF?",
        "mechanism_detail":"RNA toxicity hypothesized [@pmid:29507423; @pmid:38467784].",
        "source":[],
        "details":"Novel, reported pathogenic alleles: (TTTTA)22 (TTTCA)exp (TTTTA)exp, but only the TTTCA is specific to affected individuals (size: 1100 repeats). Non-pathogenic reference TTTTA repeat was expanded in nine healthy subjects 40-120 repeats and in two individuals was potentially even longer [@pmid:29507423].",
        "omim":[
            "618074"
        ],
        "prevalence":null,
        "prevalence_details":"FAME overall is 1/35,000 in Japan. This repeat expansion is typically found in individuals of East Asian ancestry [@pmid:38876750].",
        "stripy":[
            "TNRC6A"
        ],
        "gnomad":[
            "TNRC6A"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0054846"
        ],
        "year":"2018 [@pmid:29507423]",
        "medgen":[
            "1648448"
        ],
        "orphanet":[
            "86814"
        ],
        "gard":[
            "16758"
        ],
        "malacard":[
            "EPL227"
        ],
        "webstr_hg38":[
            "5951520"
        ],
        "webstr_hg19":[
            "STR_519979"
        ],
        "tr_gnomad":[
            "TR139999"
        ],
        "disease_description":"Cortical tremor, seizures with generalised motor (tonic-clonic) onset [@pmid:38876750].",
        "locus_tags":["sparse_evidence", "motif_affects_penetrance"],
        "disease_tags":["Familial adult myoclonic epilepsy"]
    },
    {
        "chrom":"chr1",
        "start_hg38":1435798,
        "stop_hg38":1435818,
        "start_hg19":1371178,
        "stop_hg19":1371198,
        "start_t2t":870158,
        "stop_t2t":870178,
        "id":"HMNR7_VWA1",
        "disease_id":"HMNR7",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GGCGCGGAGC"
        ],
        "pathogenic_motif_reference_orientation":[
            "GGCGCGGAGC"
        ],
        "pathogenic_motif_gene_orientation":[
            "AGCGGCGCGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Neuronopathy, distal hereditary motor, autosomal recessive 7",
        "gene":"VWA1",
        "flank_motif":null,
        "locus_structure":"(GGCGCGGAGC)*",
        "inheritance":[
            "AR"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "benign_min":2.0,
        "benign_max":2.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":1.0,
        "pathogenic_max":3.0,
        "ref_copies":null,
        "motif_len":10,
        "age_onset":"Typical: 1-3 [@pmid:33559681]; Range: 0-10 [@omim:619216].",
        "age_onset_min":0,
        "age_onset_max":10,
        "typ_age_onset_min":1.0,
        "typ_age_onset_max":3.0,
        "novel":null,
        "mechanism":"LoF",
        "mechanism_detail":"Loss of function [@pmid:38467784].",
        "source":[],
        "details":"Any deviation from 2 motifs is thought to be pathogenic [@genereviews:NBK535148].",
        "omim":[
            "619216"
        ],
        "prevalence":null,
        "prevalence_details":"Biallelic variants found in 0.01% of 100 KGP participants; enriched in those with motor disease. 80% of VWA1 pathogenic variants are expansions/contractions [@genereviews:NBK535148]. The repeat expansion was found in several ethnicities; founder mutation 7,000 years prior [@pmid:33559681].",
        "stripy":[],
        "gnomad":[
            "VWA1"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0030977"
        ],
        "year":"2021 [@pmid:33559681]",
        "medgen":[
            "1786836"
        ],
        "orphanet":[
            "314485"
        ],
        "gard":[
            "18444"
        ],
        "malacard":[
            "NRN074"
        ],
        "webstr_hg38":[
            "1099767"
        ],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR32"
        ],
        "disease_description":"Autosomal recessive distal hereditary motor neuronopathy-7 (HMNR7) is characterized by onset of lower leg weakness in the first decade. Affected individuals have difficulty climbing stairs and problems standing on the heels... Most patients have foot deformities, and some may have leg muscle atrophy. The disorder is slowly progressive and often involves the upper limbs [@omim:619216].",
        "locus_tags":["contraction"],
        "disease_tags":[]
    },
    {
        "chrom":"chr16",
        "start_hg38":17470907,
        "stop_hg38":17470922,
        "start_hg19":17564764,
        "stop_hg19":17564779,
        "start_t2t":17477910,
        "stop_t2t":17478013,
        "id":"DBQD2_XYLT1",
        "disease_id":"DBQD2, BSS",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "GCC"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Baratela-Scott Syndrome/Desbuquois dysplasia 2",
        "gene":"XYLT1",
        "flank_motif":null,
        "locus_structure":"(GCC)*",
        "inheritance":[
            "AR"
        ],
        "type":"5' UTR",
        "location_in_gene":"Intron 1",
        "benign_min":0.0,
        "benign_max":20.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":72.0,
        "pathogenic_max":110.0,
        "ref_copies":0.0,
        "motif_len":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":0.0,
        "typ_age_onset_max":0.0,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Methylation [@pmid:30554721].",
        "source":[],
        "details":"Benign range (0-20) taken from primary literatre of unaffected individuals and gnomAD data [@pmid:30554721; @gnomad:XYLT1]. Minimum repeat size to cause disease thought to range between 72 and 110 repeats [@pmid:30554721]. Repeat is within a 238bp sequence which is missing from hg38 but present in T2T-CHM13",
        "omim":[
            "615777"
        ],
        "prevalence":null,
        "prevalence_details":"<1/1,000,000 births [@orphanet:1425]; repeat expansions comprise half of DBQD variants [@genereviews:NBK535148]. <50 DBQD cases. Has been found in Belgian, Emirati families",
        "stripy":[
            "XYLT1"
        ],
        "gnomad":[
            "XYLT1"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0014343"
        ],
        "year":"2019 [@pmid:30554721]",
        "medgen":[
            "862731"
        ],
        "orphanet":[
            "1425"
        ],
        "gard":[
            "16466"
        ],
        "malacard":[
            "DSB005"
        ],
        "webstr_hg38":[
            "793606"
        ],
        "webstr_hg19":[],
        "tr_gnomad":[
            "TR139509"
        ],
        "disease_description":"Desbuquois dysplasia, which belongs to the multiple dislocation group of disorders, is characterized by dislocations of large joints, severe pre- and postnatal growth retardation, joint laxity, and flat face with prominent eyes. Radiologic features include short long bones with an exaggerated trochanter that gives a 'monkey wrench' appearance to the proximal femur, and advanced carpal and tarsal ossification [@pmid:24581741].",
        "locus_tags":[],
        "disease_tags":[]
    },
    {
        "chrom":"chr3",
        "start_hg38":183712188,
        "stop_hg38":183712222,
        "start_hg19":183429976,
        "stop_hg19":183430010,
        "start_t2t":186521657,
        "stop_t2t":186521706,
        "id":"FAME4_YEATS2",
        "disease_id":"FAME4",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "TTTTA"
        ],
        "pathogenic_motif_reference_orientation":[
            "TTTCA"
        ],
        "pathogenic_motif_gene_orientation":[
            "ATTTC"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[
            "TTTTT",
            "TGTTA"
        ],
        "unknown_motif_gene_orientation":[
            "TTTTT",
            "ATGTT"
        ],
        "disease":"Familial adult myoclonic epilepsy 4",
        "gene":"YEATS2",
        "flank_motif":null,
        "locus_structure":"(TTTTA)*(TTTCA)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "benign_min":null,
        "benign_max":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":1000.0,
        "pathogenic_max":1000.0,
        "ref_copies":10.0,
        "motif_len":5,
        "age_onset":"Typical: 20-25 [@pmid:22713812]; Range: 10-33 [@pmid:31539032].",
        "age_onset_min":10,
        "age_onset_max":33,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"novel",
        "mechanism":"GoF?",
        "mechanism_detail":"RNA toxicity hypothesized [@pmid:31539032].",
        "source":[],
        "details":"Novel insertion of ~1000 repeats observed to cause disease [@pmid:31539032].",
        "omim":[
            "615127"
        ],
        "prevalence":null,
        "prevalence_details":"FAME overall is 1/35,000 in Japan. This repeat expansion is typically found in individuals of East Asian ancestry [@pmid:38876750].",
        "stripy":[
            "YEATS2"
        ],
        "gnomad":[
            "YEATS2"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0014055"
        ],
        "year":"2019 [@pmid:31539032]",
        "medgen":[
            "767474"
        ],
        "orphanet":[
            "86814"
        ],
        "gard":[
            "16758"
        ],
        "malacard":[
            "EPL107"
        ],
        "webstr_hg38":[
            "5034940",
            "769177"
        ],
        "webstr_hg19":[
            "STR_1006941"
        ],
        "tr_gnomad":[
            "TR38932"
        ],
        "disease_description":"Cortical tremor, seizures with generalised motor (tonic-clonic) onset [@pmid:38876750].",
        "locus_tags":["sparse_evidence", "motif_affects_penetrance"],
        "disease_tags":["Familial adult myoclonic epilepsy"]
    },
    {
        "chrom":"chr16",
        "start_hg38":72787695,
        "stop_hg38":72787758,
        "start_hg19":72821594,
        "stop_hg19":72821657,
        "start_t2t":78605503,
        "stop_t2t":78605569,
        "id":"SCA4_ZFHX3",
        "disease_id":"SCA4",
        "gene_strand":"-",
        "reference_motif_reference_orientation":[
            "GCC"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCC"
        ],
        "pathogenic_motif_gene_orientation":[
            "CGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Spinocerebellar ataxia 4",
        "gene":"ZFHX3",
        "flank_motif":null,
        "locus_structure":"(GCC)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Last Exon (exact exon transcript dependent)",
        "benign_min":14.0,
        "benign_max":26.0,
        "intermediate_min":27.0,
        "intermediate_max":45.0,
        "pathogenic_min":46.0,
        "pathogenic_max":74.0,
        "ref_copies":21.3,
        "motif_len":3,
        "age_onset":"Typical: 37- 56; Range: 15 - 60 [@pmid:38035881; @pmid:38973251].",
        "age_onset_min":15,
        "age_onset_max":60,
        "typ_age_onset_min":37.0,
        "typ_age_onset_max":56.0,
        "novel":"ref",
        "mechanism":"GoF?",
        "mechanism_detail":"Potential RNA-mediated gain of functin mechanism theorized [@pmid:38467784]",
        "source":[],
        "details":"Disease-causing expansions range from 46 repeats [@pmid:38973251] to 74 repeats [@pmid:38035881]. Possible anticipation in disease [@pmid:38197134; @pmid:38035881]; intermediate alleles may correspond to premutations [@pmid:38973251]. Most unaffected individuals had 21 motifs, but benign alleles range from 14-26 repeats [@pmid:38035881].",
        "omim":[
            "600223"
        ],
        "prevalence":null,
        "prevalence_details":"Observed in Swedish individuals: 2 original kindreds and 3 additional families [@omim:600223].",
        "stripy":[],
        "gnomad":[],
        "genereviews":[],
        "mondo":[
            "0010847"
        ],
        "year":"2023 [@pmid:38035881]",
        "medgen":[
            "199815"
        ],
        "orphanet":[
            "98765"
        ],
        "gard":[
            "9970"
        ],
        "malacard":[
            "SPN105"
        ],
        "webstr_hg38":[
            "5977326"
        ],
        "webstr_hg19":[
            "STR_545217"
        ],
        "tr_gnomad":[
            "TR142346"
        ],
        "disease_description":"Spinocerebellar ataxia type 4 (SCA4) is a very rare progressive subtype of type I autosomal dominant cerebellar ataxia (ADCA type I) characterized by ataxia with sensory neuropathy (adapted from Mondo) [@mondo:0010847].",
        "locus_tags":["length_affects_onset"],
        "disease_tags":[
            "spinocerebellar ataxia"
        ]
    },
    {
        "chrom":"chr13",
        "start_hg38":99985448,
        "stop_hg38":99985493,
        "start_hg19":100637702,
        "stop_hg19":100637747,
        "start_t2t":99196359,
        "stop_t2t":99196404,
        "id":"HPE5_ZIC2",
        "disease_id":"HPE5",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Holoprosencephaly-5",
        "gene":"ZIC2",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "inheritance":[
            "AD"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 3",
        "benign_min":15.0,
        "benign_max":15.0,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic_min":25.0,
        "pathogenic_max":25.0,
        "ref_copies":15.3,
        "motif_len":3,
        "age_onset":"0",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":0.0,
        "typ_age_onset_max":0.0,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Polyalanine expansion interfering with DNA binding and transcriptional activation [@pmid:19177455; @pmid:15590697].",
        "source":[],
        "details":"The benign allele of 15 repeats expands to 25 repeats to cause disease [@genereviews:NBK51932], although the expansion can potentially present with a mild phenotype [@doi:10.1016/j.gimo.2024.101607]",
        "omim":[
            "609637"
        ],
        "prevalence":"1.4/1000000",
        "prevalence_details":"0.05-0.23/100,000; math done by 40% of pathogenic variants in ZIC2 are expansion [@genereviews:NBK1530]; 5% of non-syndromic HPE are ZIC2 gene [@genereviews:NBK1530], and nonsyndromic HPE is 25-50% of HPE, which affects 1/10,000 newborns [@url:medlineplus.gov/genetics/condition/nonsyndromic-holoprosencephaly/] - ZIC2 is 9.2% of HPE cases, which occur in 1/16,000 live births [@pmid:17274816]. Holoprosencephaly has worldwide distribution [@orphanet:2162], but STR-specific distribution is unknown.",
        "stripy":[
            "ZIC2"
        ],
        "gnomad":[
            "ZIC2"
        ],
        "genereviews":[
            "NBK51932"
        ],
        "mondo":[
            "0012322"
        ],
        "year":"2001 [@pmid:11285244]",
        "medgen":[
            "355304"
        ],
        "orphanet":[
            "2162"
        ],
        "gard":[
            "6665"
        ],
        "malacard":[
            "HLP028"
        ],
        "webstr_hg38":[
            "5374719"
        ],
        "webstr_hg19":[
            "STR_395661"
        ],
        "tr_gnomad":[
            "TR127312"
        ],
        "disease_description":"Holoprosencephaly associated with mutations in the ZIC2 gene [@mondo:0012322].",
        "locus_tags":[],
        "disease_tags":[]
    },
    {
        "chrom":"chrX",
        "start_hg38":137566826,
        "stop_hg38":137566856,
        "start_hg19":136648985,
        "stop_hg19":136649015,
        "start_t2t":135876774,
        "stop_t2t":135876800,
        "id":"VACTERLX_ZIC3",
        "disease_id":"VACTERLX",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCN"
        ],
        "pathogenic_motif_gene_orientation":[
            "CNG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"X-linked VACTERL syndrome",
        "gene":"ZIC3",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "inheritance":[
            "XR"
        ],
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "benign_min":10.0,
        "benign_max":10.0,
        "intermediate_min":11.0,
        "intermediate_max":11.0,
        "pathogenic_min":12.0,
        "pathogenic_max":12.0,
        "ref_copies":9.0,
        "motif_len":3,
        "age_onset":"0",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"Unknown",
        "mechanism_detail":"Polyalanine expansion with unknown mechanism [@pmid:17581576].",
        "source":[],
        "details":"Frequently genotyped as (NGC)*, although locus structure has been reported as (GCC)8(GCT)(GCC) [@pmid:38467784]. 1 patient with VACTERL died at birth with 12 repeats [@pmid:20452998]. 8 patients with X-linked oculo-auriculo-vertebral spectrum (OAVS) had 11 repeats (intermediate allele size); 1 individual in OAVS cohort with 12 repeats; likely phenotypic spectrum [@pmid:32639022].",
        "omim":[
            "314390"
        ],
        "prevalence":null,
        "prevalence_details":"Found in one patient [@genereviews:NBK535148] with European ancestry [@pmid:20452998].",
        "stripy":[
            "ZIC3"
        ],
        "gnomad":[
            "ZIC3"
        ],
        "genereviews":[
            "NBK535148"
        ],
        "mondo":[
            "0010752"
        ],
        "year":"2010 [@pmid:20452998]",
        "medgen":[
            "419019"
        ],
        "orphanet":[],
        "gard":[
            "15309"
        ],
        "malacard":[
            "VCT005"
        ],
        "webstr_hg38":[
            "883856"
        ],
        "webstr_hg19":[
            "STR_1596381"
        ],
        "tr_gnomad":[
            "TR173313"
        ],
        "disease_description":"VACTERL is an acronym for vertebral anomalies (similar to those of spondylocostal dysplasia), anal atresia, cardiac malformations, tracheoesophageal fistula, renal anomalies (urethral atresia with hydronephrosis), and limb anomalies [@omim:314390].",
        "locus_tags":["sparse_evidence"],
        "disease_tags":["phenotypic_spectrum"]
    },
    {
        "chrom":"chr7",
        "start_hg38":55887601,
        "stop_hg38":55887639,
        "start_hg19":55955294,
        "stop_hg19":55955332,
        "start_t2t":56047901,
        "stop_t2t":56047939,
        "id":"FRA7A_ZNF713",
        "disease_id":"FRA7A",
        "gene_strand":"+",
        "reference_motif_reference_orientation":[
            "GCG"
        ],
        "pathogenic_motif_reference_orientation":[
            "GCG"
        ],
        "pathogenic_motif_gene_orientation":[
            "CGG"
        ],
        "benign_motif_reference_orientation":[],
        "benign_motif_gene_orientation":[],
        "unknown_motif_reference_orientation":[],
        "unknown_motif_gene_orientation":[],
        "disease":"Autism spectrum disorder associated with fragile site FRA7A",
        "gene":"ZNF713",
        "flank_motif":null,
        "locus_structure":"(GCG)*",
        "inheritance":[
            "AD"
        ],
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "benign_min":5.0,
        "benign_max":22.0,
        "intermediate_min":42.0,
        "intermediate_max":85.0,
        "pathogenic_min":450.0,
        "pathogenic_max":450.0,
        "ref_copies":13.0,
        "motif_len":3,
        "age_onset":"2-3 (four individuals) [@pmid:25196122].",
        "age_onset_min":2,
        "age_onset_max":3,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "mechanism":"LoF",
        "mechanism_detail":"Methylation, evidence of transcriptional misregulation [@omim:616181; @pmid:25196122].",
        "source":[],
        "details":" 176 controls were used to establish the benign range (5-22 repeats), whereas a singular proband was identified with ~450 repeats [@pmid:25196122]. The observed intermediate alleles were presumed to function as premutations, with variable amounts of methylation [@pmid:25196122]",
        "omim":[
            "616181"
        ],
        "prevalence":null,
        "prevalence_details":"1 proband reported alongside 3 individuals with premutations, found in 2 families without discussion of ancestry/ethnicity [@pmid:25196122].",
        "stripy":[],
        "gnomad":[],
        "genereviews":[],
        "mondo":[],
        "year":"2014 [@pmid:25196122]",
        "medgen":[],
        "orphanet":[],
        "gard":[],
        "malacard":[
            "ATS007"
        ],
        "webstr_hg38":[
            "1380240",
            "5696269"
        ],
        "webstr_hg19":[
            "STR_1325788"
        ],
        "tr_gnomad":[
            "TR300995"
        ],
        "disease_description":"A spectrum of developmental disorders that includes autism, and Asperger syndrome. Signs and symptoms include poor communication skills, defective social interactions, and repetitive behaviors [@mondo:0005258].",
        "locus_tags":["sparse_evidence"],
        "disease_tags":[]
    }
]
